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Abstract (250 words) 
This article is a systematic review of evidence regarding the impact of 
different lighting conditions on the vision and quality of life (QoL) of people with 
primary open-angle glaucoma (POAG).  
A systematic literature search was carried out using CINAHL, MEDLINE, 
PsycARTICLES, PsycINFO, Embase and Ovid Nursing Database for studies: 
published up to April 2019, including people diagnosed with POAG, and assessing 
visual function or QoL in response to changing lighting/luminance levels or glare. 
Two researchers independently screened studies for eligibility. Data were extracted 
What was known before 
• Glaucoma is a progressive optic neuropathy which may have few symptoms in 
its early stages.  
• Some evidence points to difficulties people with glaucoma may experience in 
extremes of lighting (e.g. very bright or very dark conditions) or when 
transitioning between different luminance levels (e.g. light or dark adaptation). 
• Dark adaptation and glare are common concerns in patient-reported outcome 
measures of vision-related quality of life in glaucoma.  
What this review adds 
• This systematic review, including 56 studies, is the first to focus on the impacts 
of lighting and luminance conditions on people with glaucoma. 
• Issues with lighting, especially lighting extremes or transitions, are highly 
prevalent in glaucoma and become worse with increasing visual field loss. 
However lighting concerns do not feature among glaucoma patients’ most 
bothersome concerns. 
• Psychophysical studies suggest glaucoma negatively affects low-luminance 
contrast sensitivity, glare symptoms, and dark adaptation time and extent. 
However, performance-based studies seldom show significant differences 
between individuals with glaucoma and age-matched controls on tasks 
simulating daily activities under non-optimal lighting conditions. 
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from eligible studies regarding study design, participant characteristics, outcomes 
and results. Quality of included studies was critically appraised.  
Of 8437 studies, 56 eligible studies were included. Studies investigated the 
effects of lighting on the following themes among people with POAG: QoL (18/56), 
psychophysical measures (16/56), functional vision (10/56), activities of daily living 
(10/56) and qualitative findings (2/56).  
POAG negatively affects low-luminance contrast sensitivity, glare symptoms, 
and dark adaptation time and extent. In vision-related QoL questionnaires, people 
with POAG report problems with lighting, glare and dark adaptation more frequently 
than any other domain. These problems worsen with progressing visual field loss. 
Early-stage POAG patients experience significantly more difficulties in low-luminance 
or changing lighting conditions than age-matched controls (AMCs), challenging 
perceptions of early-stage POAG as asymptomatic. However, performance-based 
studies seldom show significant differences between POAG participants and AMCs 
on tasks simulating daily activities under non-optimal lighting conditions. Further 
research with larger samples is required to optimise ambient and task-oriented 
lighting that can support patients’ adaptation to POAG.     
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Introduction 
Glaucoma refers to a heterogeneous group of diseases which damage the 
optic nerve and visual field (VF). Globally, glaucoma is the most frequent cause of 
irreversible blindness, with an estimated age-standardised prevalence of 
approximately 3.5% among people aged 40 or older.1  
Primary open angle glaucoma (POAG) comprises 74% of all glaucoma 
cases.2 By 2020, it is expected that POAG will affect around 53 million people 
worldwide.3 POAG is a chronic, progressive disease which may not have obvious 
symptoms until significant VF loss has occurred. It can therefore remain undetected 
in up to half of cases, yet people with POAG may maintain good visual outcomes 
with prompt diagnosis and treatment.4 Since the condition is often asymptomatic in 
the early stages, it is important to understand associated functional changes. This 
may in turn help develop new methods to raise awareness of POAG’s impacts, thus 
facilitating help-seeking and potential diagnosis.5   
This review will include studies that consider how lighting levels affect people 
with glaucoma at the mild, moderate and advanced disease stages. This is of 
significant clinical interest, as there is some evidence that early-stage POAG, often 
considered asymptomatic, may cause issues in non-standard lighting conditions. For 
example, a recent study suggests that differences in the vision of early-stage 
glaucomatous patients compared to healthy controls may be magnified in non-
optimal luminance conditions.6 This systematic review therefore aims to draw 
together evidence on how different light levels affect visual function and vision-
related QoL among people with glaucoma, from psychophysical studies, patient 
reported outcome measures (PROMs) and performance-based tasks. Vision-related 
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QoL can be considered as “the degree to which vision impacts an individual’s ability 
to complete activities of daily living and one’s social, emotional and economic well-
being”.7 Table 1 provides a glossary of key lighting terminology used here. 
Table 1. Glossary of lighting-specific terms  
Term Definition 
Glare 
Disability glare 
Discomfort glare 
A visual sensation caused by excessive brightness. 
Reduced vision caused by light scatter from a bright source. 
Sensation of discomfort or annoyance caused by bright light.8 
Luminance Intensity of light per unit area traveling in a certain direction.9  
Mesopic Mesopic conditions exist in the range between photopic and 
scotopic, and mesopic vision involves both rods and cones.  
Photopic Photopic conditions are well-lit (e.g. outside on a sunny day), and 
photopic vision involves cones, facilitating colour perception. 
Scotopic Scotopic conditions are low light conditions (e.g. outside at night 
under starlight). Scotopic vision involves only rods, providing 
limited colour perception. 
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Methods 
A search of the electronic databases CINAHL Complete, MEDLINE Complete, 
PsycARTICLES and PsycINFO (via EBSCOhost) and Embase and Ovid Nursing 
Database (via OVID) was undertaken. Keywords used related to (open angle) 
glaucoma, and a group of terms relating to lighting, brightness, darkness, glare, 
luminance and photopic/mesopic/scotopic conditions. For detailed search terms, see 
Appendix 1. Prospective and retrospective citation tracking was performed using 
Scopus and Google Scholar.  
Studies considered eligible for inclusion were those that involved people 
diagnosed with glaucoma, and were written in English, French or Spanish. Studies 
were required to include at least some participants with chronic primary open angle 
glaucoma (POAG). If studies solely involved participants with other types of 
glaucoma (e.g. angle-closure glaucoma or congenital glaucoma), they were 
excluded. Additionally, included studies had to consider the impact of different 
general or task lighting conditions on vision and vision-related QoL. For example, 
because “photopic” was a keyword, many articles were returned about the photopic 
negative response, a test using the electroretinogram which can detect retinal 
ganglion cell dysfunction. Such articles were not included, because this is a very 
specific clinical use of light that is distinct from how photopic environmental 
conditions affect people with POAG. Studies were also excluded if their main interest 
related to colour, such as how specific wavelengths or coloured light (e.g. blue light) 
may affect people with open angle glaucoma.  
Review articles were excluded, as were studies where only an abstract was 
published (e.g. conference proceedings). However due to the heterogeneity of the 
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phenomena under investigation, and the pragmatic orientation of this review, studies 
with only abstracts available are considered in Appendix 4, to avoid omitting 
potentially useful insights.  
Two authors (JE and LJ) screened studies using Covidence systematic review 
software (Veritas Health Innovation Ltd, Melbourne, Australia; available at 
www.covidence.org) to assess eligibility. In the case of disagreements unresolved 
through discussion, a third author (DJT) was consulted. Relevant information (e.g. 
publication details, characteristics of participants, study design, outcomes measured, 
study results, and conclusions) from eligible papers was entered into a data 
extraction table. 
Studies were assessed for quality using Kmet, Lee and Cook’s Standard 
Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety 
of Fields.10 This quality appraisal was chosen because of the variety of quantitative 
and qualitative studies which are relevant to the review’s questions, spanning 
several research fields. Full details of assessment criteria are shown in Table 2. This 
review is registered with the International prospective register of systematic reviews 
(PROSPERO; http://www.crd.york.ac.uk/prospero/ ; Reference CRD42018118953). 
 
Table 2. Kmet, Lee and Cook (2004) quality assessment checklists. For each 
question, the checklist authors provide guidance on study aspects which should be 
considered when making a decision. For example, on Quantitative checklist 
Question 4 (Subject characteristics sufficiently described?), to score a Yes (2), the 
study in question must provide at least the age and sex of control participants. 
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Quantitative studies Qualitative studies 
1. Question / objective sufficiently described? 
2. Study design evident and appropriate? 
3. Method of subject/comparison group 
selection or source of information/input 
variables described and appropriate? 
3. Context for the study clear? 
 
4. Subject (and comparison group, if 
applicable) characteristics sufficiently 
described? 
4. Connection to a theoretical 
framework / wider body of 
knowledge? 
5. If interventional and random allocation was 
possible, was it described? 
5. Sampling strategy described, 
relevant and justified? 
6. If interventional and blinding of investigators 
was possible, was it reported? 
6. Data collection methods 
clearly described and 
systematic? 
7. If interventional and blinding of subjects was 
possible, was it reported? 
7. Data analysis clearly 
described and systematic? 
8. Outcome and (if applicable) exposure 
measure(s) well defined and robust to 
measurement / misclassification bias? Means 
of assessment reported? 
8. Use of verification 
procedure(s) to establish 
credibility? 
9. Sample size appropriate? 9. Conclusions supported by the 
results? 
10. Analytic methods described/justified and 
appropriate? 
10. Reflexivity of the account? 
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11. Some estimate of variance is reported for 
the main results? 
 
12. Controlled for confounding?  
13. Results reported in sufficient detail?  
14. Conclusions supported by the results?  
 
Results  
Searches were run on 1 April 2019 and yielded 21,009 results (to which 10 
further studies were added through reference list searching). Of these, 12,582 were 
automatically removed as duplicates. This left 8,437 studies to screen using title and 
abstract, of which 8,125 were excluded and 312 articles were assessed for full-text 
eligibility. Many studies were excluded at the title and abstract screening stage 
because they involved animals or concerned aspects of glaucoma unrelated to 
lighting. Ultimately, 56 full-text studies were selected for inclusion. The study 
selection process is shown in a PRISMA diagram in Figure 1. Fifty-four of the 56 
studies (96%) were quantitative, and two (4%) were qualitative.  
Quality appraisal was conducted on 55 studies. One study11 could not be 
quality assessed as it dated from 1929 and was not presented in a format that 
allowed for comparison with other studies. The lowest and highest score was 0.67 
and 1.00 respectively (i.e. all responses to relevant questions in the Kmet, Lee and 
Cook criteria was Yes). Frequent issues were limited information about 
subject/comparison group selection and limited description of group characteristics 
(Figure 2). Appendix 2 shows quality appraisal results for the 53 quantitative and 2 
qualitative studies.  
11 
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Figure 1. PRISMA diagram showing study selection process 
 
 
Sc
re
en
in
g 
In
cl
ud
ed
 
El
ig
ib
ili
ty
 
Id
en
tif
ic
at
io
n 
Records identified through database 
searching (n = 21,009) 
Additional records identified through 
other sources (n = 10) 
Records after duplicates removed (n = 8,437) 
Records screened for relevance  
(n = 8,437) 
Records excluded (n = 8,125) 
Full-text articles assessed for eligibility  
(n = 312) 
Full-text articles excluded, with 
reasons 
(n = 256) 
• Psychophysical or physiological 
studies out of scope (102) 
• Colour/chromatic (53) 
• In language other than English, 
French or Spanish (26) 
• Further duplicates not identified 
at initial screening (21) 
• Not relevant to lighting (17) 
• Full article not available (16) 
• Review (12) 
• Not relevant to glaucoma (8) 
• Animal study (1) 
Studies included in review 
(n = 56) 
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Figure 2. Quantitative study (N= 53) quality appraisal results
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For full details of included studies, see the data extraction table (Appendix 3). 
The subsequent overview of study findings is organised according to main outcome 
domain. Figure 3 shows the different domains of the studies included in this review, 
the most frequent of which was QoL (32% of studies), followed by psychophysical 
measures (29%). The vast majority of the included studies were case-control (48%) 
and cross-sectional (41%) studies. 
Figure 3. Thematic domains considered in the included studies  
 
Quality of life (QoL) 
 Eighteen studies (32%) explored how lighting conditions affected QoL among 
people with glaucoma. Eleven of the 18 (61%) studies were cross-sectional while 
seven (39%) were case-control studies. In total, 2,354 participants with glaucoma 
were involved in the 11 cross-sectional studies. In the case-control studies, there 
were 708 participants with glaucoma and 539 control participants. All the studies in 
this section explored QoL using patient-reported outcome measures (PROMs), 
including both novel questionnaires and ones extensively developed, tested and 
validated for use.12   
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 Twelve of the 18 QoL studies explicitly excluded individuals with “visually 
significant”, “clinically significant” or “dense” cataracts. Five cross-sectional studies 
provided no information about whether participants were excluded on the basis of 
cataracts, while in one case-control study six of the 68 glaucoma cases also had 
cataracts.13 The majority of case-control studies controlled for age when analysing 
their main results, by matching groups by age and/or by adjusting for the influence of 
age. However, in two studies with significant differences between glaucomatous and 
control participants,14 15 the review authors could not establish whether the lighting-
relevant findings were adjusted for age. 
 
Novel questionnaires 
Nelson et al.’s study of 63 glaucoma patients found significant differences in 
adjusting to bright lighting (P = 0.02) and disability glare (P = 0.02) when comparing 
participants with mild/moderate glaucoma against those with advanced glaucoma 
(severe binocular VF loss).16 There was also a marginal, though non-significant 
difference in adaptation, when transitioning from a bright to dark room or vice versa 
(P = 0.055). In the authors’ questionnaire on visual disability when performing daily 
activities, the most commonly reported problems were glare (reported as a difficulty 
by 70% of participants), and adaptation to different lighting levels (reported by 54%).  
The Glaucoma Symptom Scale was developed by Lee et al (1998) using data 
from 147 participants with glaucoma and 44 individuals without eye disease.17 Of the 
glaucomatous participants, 120 (82%) reported problems seeing in the dark, versus 
14 (32%) in the control group. Fifty-eight (39%) glaucomatous participants reported 
haloes around lights, versus 6 (14%) participants in the control group. Sixty-nine 
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(46%) glaucomatous participants had problems seeing in daylight, versus 7 (16%) in 
the control group. There was a significant difference in age between glaucomatous 
and control participants (P < 0.01), though multivariate linear regression adjusted for 
age still showed significant differences (P < 0.001) between groups on these 
questionnaire items. The multivariate model also controlled for presence of cataract, 
although there were few cataract cases and their inclusion did not substantively 
affect overall scores, even without correction. 
A later study by Mogil et al. (2017)18 adapted validated questionnaires such as 
the National Eye Institute Visual Function Questionnaire (NEI-VFQ) and Glaucoma 
Quality of Life (GQL-15) to create a new questionnaire with five domains: general 
eyesight, visual symptoms, activities, socioeconomic factors, and ocular symptoms. 
This was administered to 152 glaucomatous participants, including 97 with POAG. In 
the visual symptom domain, difficulty seeing in the dark was the second-most 
common concern (reported by 21% of participants) and glare the third most common 
(reported by 15%). However, a non-lighting specific concern, blurry vision, was the 
most common visual symptom (32%). Difficulty “adjusting to changes in light 
settings” was reported by 4% of participants. 
 
Glaucoma Quality of Life (GQL-15) 
The GQL-15 questionnaire was first compiled and tested by Nelson et al. 
(2003).19 The authors found that glare disability, as tested with the brightness acuity 
test, correlated moderately with summary score on the GQL-15 (r = −0.41; P < 
0.001). Furthermore, dark adaptation, as tested using the Goldmann Weekers Dark 
Adaptometer, correlated moderately with improved scores on the GQL-15 (r = 0.34, 
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P = 0.007). Out of the psychophysical tests used by the authors, only the correlation 
between GQL-15 summary score and Pelli-Robson contrast sensitivity was stronger 
(r = −0.45; P < 0.001). The authors suggest that of the four different GQL-15 
subscales (central and near vision; peripheral vision; glare and dark adaptation; and 
outdoor mobility), the glare and dark adaptation questions could best distinguish 
between glaucoma severity group (mild, moderate or severe). Glare and dark 
adaptation showed lower (worse) scores than the other three subscales at each 
glaucoma severity level. There were no significant differences in age between 
groups, and results were adjusted for the influence of small inter-group differences in 
age. 
The GQL-15 was used to compare a group of 121 participants with glaucoma 
(subdivided into mild, moderate and severe) with 31 healthy controls.14 There was no 
significant difference in scores on the glare and dark adaptation scale between 
participants with mild glaucoma and controls, whereas the glaucoma participants 
were significantly more compromised than controls on all the other three GQL-15 
subscales (central and near vision, peripheral vision, and outdoor mobility). 
Nonetheless, scores were consistently higher/worse for controls and glaucoma 
participants at each stage of severity on the glare and dark adaptation subscale than 
for any other subscale. Controls were on average seven years younger than 
glaucoma participants (P < 0.001). 
The finding that glare and dark adaptation emerges for both glaucoma 
participants (at each disease stage) and age-matched controls as the most 
problematic of the four GQL-15 subscales has been found in other studies, such as 
Onakoya et al.20 Additionally, when a Chinese version of the GQL-15 was 
administered to 508 glaucoma patients, the worst scores (out of the four subscales) 
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were reported for glare and dark adaptation, closely followed by central and near 
vision.21 In a Serbian translation of the GQL-15, the glare and dark adaptation 
subscale showed the worst score, with no significant difference between mild 
(N=101) and moderate (N=38) glaucoma stages, but with advanced glaucoma 
(N=38) participants showing significantly worse scores.22 Another translation of the 
GQL-15 into Chinese found that the most problematic activities related to lighting 
transitions and dark adaptation. Across glaucoma severity, participants had worst 
scores for the questionnaire items “adjusting to bright lights” and “going from a light 
to a dark room or vice versa”.23 The third worst score was for “seeing at night”. 
Studies by Aspinall and colleagues nuanced this finding that glare and dark 
adaptation is the most consistently problematic subscale on the GQL-15, by 
exploring how glaucoma patients prioritise their QoL concerns. Aspinall et al. (2008) 
found that lighting and glare were the most frequently reported problems, but third in 
a priority list after central vision and outdoor mobility.24 An earlier study by Aspinall et 
al. (2005) with a different sample of patients similarly illustrated that despite their 
frequency, the subjective importance of glare and dark adaptation problems may be 
relatively low.25 The authors suggest that the low relative impact of glare and dark 
adaptation on QoL may be explained by the feasibility of accommodating to the 
changes through behavioural or environmental modifications. The authors also found 
that of the different attributes of vision-related QoL, contrast sensitivity only had an 
effect on the prioritisation of the glare and dark adaptation subdomain (P = 0.038). 
A QoL assessment among participants in the Collaborative Initial Glaucoma 
Treatment Study (CIGTS) came to a similar conclusion: that lighting and glare issues 
may be frequent concerns, but not necessarily the most bothersome.26 The authors 
found that at baseline of enrolment into CIGTS, over 40% of participants 
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experienced problems with bright light and light-to-dark adaptation the most 
frequently reported problems. Furthermore, almost 30% of participants reported 
problems seeing in dark places. However, rating their symptoms on a 1 (not at all) to 
5 (a lot) scale of how bothersome symptoms were, participants’ worst symptoms 
related to visual distortion (mean bothersome score: 4.1) and distant vision (mean 
bothersome score 3.8), compared to a mean score of 3.5 for bright light, 3.2 for dark 
adaptation, and 3.3 for seeing in the dark.  
 
Glaucoma Activity Limitation (GAL-9) 
One study by Skalicky and colleagues (2016) included 200 participants with 
glaucoma, 73 of whom also had some degree of age-related macular degeneration 
(AMD).15 The authors found that adjusting to dim lights was one of the GAL-9 items 
which was significantly more difficult for glaucoma patients without AMD than those 
with AMD (P = 0.04). All other GAL-9 items with reference to light (“Walking after 
dark”; “Seeing at night”; and “Going from light to dark room or vice versa”) were all 
more difficult for study participants with glaucoma alone, compared to those with 
both glaucoma and AMD, although these differences were not statistically significant 
(P = 0.20, 0.42 and 0.11 respectively). 
A hospital-based study with 50 glaucoma participants showed that among 
GAL-9 items, “adjusting to dim lights” and “going from light to dark room and vice 
versa” had a relatively high difficulty score. However of all GAL-9 domains, 
“Adjusting to dim lights” had the weakest correlation with VF damage in the central 
10 degrees (r = −0.147, P = 0.309).27 
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Comparisons between different PROMs 
A study comparing the GQL-15 with the NEI-VFQ-25 among 132 glaucoma 
participants and 132 age-matched control participants found a strong correlation 
between the glare and dark adaptation subscale of the GQL-15 and the distance 
activities domain of the NEI-VFQ-25.28 The driving domain of the NEI-VFQ-25 most 
strongly correlated with the glare and dark adaptation subscale out of the four GQL-
15 subscales (rho = -0.644, P < 0.01). Glare and dark adaptation GQL-15 scores 
became higher/worse as glaucoma severity increased, particularly when comparing 
mild and severe. A moderate association was found between mean deviation, and 
glare and dark adaptation scores (rho = 0.374).  
Kumar and colleagues29 compared two glaucoma-specific PROMs, the GQL-
15 and the 10-item questionnaire developed by Viswanathan et al.30, with the NEI-
VFQ-25 (a generic ophthalmology PROM). In total, 140 participants with glaucoma 
(49 with mild glaucoma, 55 with moderate glaucoma, and 36 with severe glaucoma) 
completed all three instruments. The authors found that scores from the three 
instruments correlated especially well in the domain of glare and dark adaptation, as 
well as peripheral vision. When comparing the NEI-VFQ-15 subscales and GQL-15 
subdomains, the NEI-VFQ-15 driving subscale had a strong correlation with the 
GQL-15’s glare and dark adaptation subdomain (r = -0.615).   
Wren et al. (2009) compared the NEI-VFQ with the Visual Activities 
Questionnaire (VAQ) among participants enrolled in the Collaborative Initial 
Glaucoma Treatment Study.31 Of the eight subscales on the VAQ, the light-dark 
adaptation subscale was the most problematic for participants, followed by glare 
disability. Light-dark adaptation on the VAQ correlated most strongly with Distance 
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Activities (r = 0.56) and Near Activities (r = 0.53) on the NEI-VFQ, while glare 
disability correlated most with Distance Activities (r = 0.51) of all the NEI-VFQ 
subscales. The driving subscale of the NEI-VFQ only had moderate correlations with 
light-dark adaptation (r = 0.44) and glare disability (r = 0.43) on the VAQ. 
Sherwood and colleagues (1998) used several questionnaires with 56 
participants with glaucoma and 54 healthy controls (who did not differ significantly in 
age, P = 0.10).13 They used the Activities of Daily Vision Scale (ADVS), and of the 
six subscales (day vision; night vision; far vision; near vision; glare; overall vision), 
the glare item showed the greatest difference in mean score between patients and 
controls. Investigating correlations between ADVS and Medical Outcomes Study 
Test (MOS-20) scores, glare had significant associations with the physical, role, 
mental health and general health subscales of MOS-20, although was not 
significantly correlated with the social and pain MOS-20 domains. 
 
Psychophysical measures 
Sixteen included studies (29% of the total) considered how specific lighting 
conditions affect psychophysical outcomes such as contrast sensitivity, glare, and 
dark/light adaptation. These studies in total involved 517 participants with diagnosed 
glaucoma, and 205 participants with suspected glaucoma. The majority (14/16 = 
88%) of the psychophysics studies were case-control studies, while two were cross-
sectional studies. 
Studies considering how glaucoma affects psychophysical measures such as 
glare and dark adaptation generally considered how age and presence of cataracts 
could influence results. Among the 14 case-control studies, five studies reported 
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mean ages of glaucoma and control groups which were clearly matched; five studies 
adjusted for age at analysis stage; while four only provided minimal information on 
participant age (e.g. an indicative age range). Regarding cataract, three of the 16 
studies expressly excluded participants with cataracts, while two studies deliberately 
included participants with cataracts. Five studies more broadly excluded people with 
“eye abnormalities”, while two studies excluded individuals who had undergone 
previous cataract surgery. Four studies gave no indication of having excluded 
individuals with cataracts.  
 
Contrast sensitivity (CS) 
Using luminance-modulated gratings, CS thresholds at all spatial and 
temporal frequencies have been found to be significantly poorer among people with 
early to moderate stage OAG relative to healthy age-matched controls.32  
Foveal CS is lower in glaucomatous eyes than eyes of age-matched controls 
in both mesopic and photopic conditions, even in glaucomatous participants with 
good visual acuity.33 For example, foveal CS, across luminance conditions, has been 
found to be 0.4 log units lower for glaucomatous participants than for controls (age-
adjusted P < 0.001).34  
However, differences in CS between healthy participants and people with 
glaucoma appear more pronounced in mesopic than photopic lighting conditions.35 
Even when differences in CS between glaucoma participants and age-similar 
controls are fairly modest overall, the difference is greater in lower luminance 
conditions.36 Furthermore, differences between glaucoma participants and age-
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matched controls in CS in the peripheral VF are most pronounced at low luminance 
levels.34 
 
Glare 
Glaucomatous damage has been found to be moderately positively correlated 
with increased glare factor (rho = 0.485; P = 0.01), with glare factor being the 
difference between log CS with glare and log CS without glare.37 It should be noted, 
however, that this finding comes from a study in which all participants had cataract. 
Disability glare among people with open-angle glaucoma has also been linked 
with macular pigment levels. For example, one study by Siah and colleagues38 found 
that 54 of 88 glaucomatous participants (61%) complained of glare symptoms. 
Among these participants reporting glare symptoms, lower macular pigment optical 
density was found at all retinal eccentricities (for 0.25° and 1°, P =0.05 each; for 0.5°: 
P =0.04). There was no difference in age between participants with and without glare 
symptoms (P = 0.51); the authors controlled for the presence of mild cataract and 
excluded individuals with moderate-to-significant cataract. 
 
Dark adaptation 
Much of the knowledge regarding dark adaptation among people with 
glaucoma is based on studies from the early- and mid-20th century.  
Derby and colleagues (1929) showed that dark adaptation was abnormal in 
healthy eyes of participants who had a confirmed glaucoma diagnosis in their other 
eye.11 The authors attempted to recruit controls of similar age to the glaucomatous 
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participants (between 50 and 70) although no exact data are provided. Derby et al. 
also suggest that changes in the minimum amount of light which the eye can 
perceive could be one of the earliest signs of glaucoma. 
It was thus hypothesised that the dark adaptation thresholds of glaucoma 
patients were reached later and were higher than in healthy eyes. Subsequently, 
Zuege and Drance (1967) showed that eyes with advanced glaucoma could be 
distinguished from age-matched healthy eyes by using the dark adaptation threshold 
ratio 15:30 degrees from fixation.39  
Relating to problems with dark adaptation experienced by people with POAG 
is the loss of scotopic sensitivity. In one study by Drum and colleagues (1986), 
participants with suspected glaucoma (no measurable VF loss, but intraocular 
pressure > 20 mm Hg) and participants with confirmed glaucoma had elevated 
scotopic and photopic adaptation thresholds. However, among participants with 
confirmed glaucoma, the scotopic threshold elevation was significantly greater than 
the photopic threshold elevation (i.e. loss of scotopic sensitivity was greater than loss 
of photopic sensitivity). In addition, it was also found that the localised scotomas of 
glaucomatous participants were of similar depth in scotopic and photopic conditions, 
but in scotopic conditions, scotomas were spread out more “diffusely” across the 
VF.40 When stratified by age, Drum et al. found that in their <40 age bracket, 
glaucomatous and control participants were indistinguishable, while in the 40-60 age 
bracket, inter-group differences were only seen for the scotopic condition. 
Progressing optic nerve damage underpins decreased dark adaptation among 
people with glaucoma. This has been demonstrated in a study involving participants 
with glaucomatous and non-glaucomatous optic nerve atrophy.41 While the authors 
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found that the extent and velocity of dark adaptation decreases with increasing age, 
after controlling for age several measurements were significantly worse among 
people with glaucoma, and even worse with the non-glaucomatous optic nerve 
atrophy group (who had more severe optic nerve damage than the glaucoma group).  
Bierings and colleagues (2018) recently showed that age-adjusted dark 
adaptation times are similar between glaucoma participants and controls, with only 
marginally (statistically non-significant) longer times among glaucoma patients 
relative to controls (P = 0.10 for 5 log unit luminance change, and P = 0.14 for 6.5 
log unit luminance change).42 In keeping with earlier studies, they found that the dark 
adaptation curve for glaucoma participants has a lower CS plateau. To explain these 
results in line with previous findings that people with glaucoma may struggle to 
adjust to low luminance conditions, the authors suggest that glaucoma participants 
may not strictly take longer to dark adapt to their plateau; however, because the CS 
plateau is lower for glaucoma participants, they will take longer when dark adapting 
to reach their minimum CS required for adequate everyday vision.42  
 
Light adaptation 
In contrast to the numerous studies focused on dark adaptation, only one 
included study considered light adaptation, examining 23 glaucoma participants and 
51 controls.42 The study authors were unable to measure light adaptation times 
because of how quickly this occurred. However, in line with findings on dark 
adaptation, they found that after light adaptation, glaucoma participants have a lower 
CS plateau than healthy control participants (after adjusting for age).  
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Visual evoked potentials (VEP) 
Arvind and colleagues (2011) explored the specific luminance aspects of the 
blue-on-yellow (BonY) multifocal visual evoked potential as a tool for identifying early 
glaucoma.43 This study found that using a low-luminance contrast achromatic (LLA) 
stimulus worked as effectively as BonY in identifying early glaucoma, while a high-
luminance contrast achromatic stimulus performed significantly worse than LLA and 
BonY in identifying VF problems. They conclude that the low-luminance contrast 
aspects of the BonY stimulus specifically may explain BonY’s usefulness in detecting 
early glaucoma.  
 
Retinal function 
One study used the modified global flash multifocal electroretinogram (ERG) 
paradigm with luminance modulation, which allows adaptive changes in the retina to 
be measured.44 The authors found that in response to a global flash stimulus at 
different luminance levels, participants with glaucoma had a reduced response 
compared to age-matched controls which correlated with glaucomatous VF damage 
(r = 0.58, P < 0.0001).  
In response to flash ERG after dark adaptation, glaucoma patients showed 
longer implicit times than age-matched controls at several flash intensities, but 
especially for high intensity flash.45 
A retinal sensitivity test (using flashing white light) performed under scotopic 
conditions has been shown to discriminate between healthy and glaucomatous 
participants. The study involved participants with suspected, as well as confirmed, 
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glaucoma, and the test effectively indicated signs of early optic nerve injury among 
glaucoma suspects.46 
 
Functional vision 
Ten studies (18%) focussed on how functional vision changes under different 
lighting conditions. Five of the 10 studies were case-control studies, three were 
cross-sectional and two were descriptive case-series. In the case-control studies, 
there were 355 participants with confirmed glaucoma and 285 controls. There were 
359 glaucomatous participants in the two cross-sectional studies, and 98 glaucoma 
participants in the two descriptive case-series. 
 
Functional difficulties linked to lighting conditions 
Among participants with early or moderate glaucoma (33 of 99 study 
participants), the most commonly reported visual symptoms were needing more light 
(58%), blurry vision (52%) and seeing glare (52%).47 When considering all 
participants in this study, needing more light was reported as a symptom by 57% of 
participants, blurry vision by 55% and seeing glare by 46%.  
The assessment of key markers of visual function among people with 
glaucoma has been shown to be dependent on lighting conditions. One study 
compared measures such as distance and near visual acuity (VA) and CS in the 
clinic and at home, with glaucomatous participants and healthy controls.48 29% and 
22% of glaucoma participants read at least two more lines of a distance VA chart 
and near VA chart respectively in the clinic than at home. 10% of glaucoma 
28 
 
participants read at least two triplets of a Pelli-Robson chart better in the clinic than 
at home. Multivariable regression analysis demonstrated that lighting levels were the 
strongest single factor associated with improved visual performance in the clinic. 
Across the whole sample of glaucoma and healthy participants, at least 85% of 
home lighting levels assessed were lower than recommended levels. Among 
glaucomatous participants, there was no statistically significant difference in lighting 
levels by glaucoma severity. This finding is reaffirmed by Yonge et al. (2017), who 
found that that individuals with more severe glaucoma symptoms were no more likely 
to adapt their home lighting than those with less advanced symptoms.49 
 
Functional difficulties linked to glare 
A descriptive study in an Australian low vision clinic reported the high 
prevalence of self-reported glare problems, with 34% of those whose low vision is 
primarily linked to glaucoma reporting being greatly affected by glare, and an 
additional 38% of patients being moderately affected.50 Prevalence of glare problems 
was even higher among those with low vision whose secondary cause was 
glaucoma; with these patients, 49% were greatly affected and 29% moderately 
affected by glare.  
 
Functional difficulties linked to transitions in lighting or luminance 
One recent questionnaire study by Bierings and colleagues (2018) compared 
the responses of 178 glaucomatous and 182 control participants to fifteen questions 
about visual function when performing activities in conditions such as outdoor at 
night (low luminance), outdoor on a sunny day (high luminance), and sudden 
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increases or decreases in luminance level.51 Participants were considered to have 
visual complaints if they responded to such questions with either ‘A lot of difficulty’, 
‘Extreme difficulty’ or ‘Stopped doing this because of my eyesight’. The authors 
found that 4% of participants with glaucoma had visual complaints in optimal 
luminance versus 0% of control participants (P = 0.02). Meanwhile 48% of 
participants with glaucoma versus 6% of controls (P < 0.001) experienced visual 
problems in low luminance conditions. The percentages of glaucoma participants 
versus controls with visual complaints was respectively 22% versus 1% for high 
luminance (P < 0.001), 32% versus 1% for a sudden decrease in luminance (P < 
0.001) and 25% versus 3% for a sudden increase in luminance (P < 0.001). The 
largest differences between glaucoma participants and controls were found for the 
low luminance questionnaire items. 48.4% of glaucoma participants reported 
complaints for “Seeing outside at night when there is no moonlight” (compared to 
6.3% of controls); 53.6% for “Walking or cycling at night on an unlit country road” 
(compared to 13.7% of controls); and 49.7% for “Driving at night on an unlit country 
road” (compared to 12.7% of controls). The study illustrates the particular difficulties 
experienced by many people with glaucoma when performing daily activities in dark 
conditions. Further, the majority (62%) of glaucoma patients in the study were 
considered to have early glaucoma in their least affected eye. As such, the findings 
suggest that glaucoma symptoms may be exacerbated in non-standard luminance 
conditions even if a patient is largely asymptomatic in optimal luminance. 
In contrast, an older questionnaire study by Carta and colleagues (1998) 
found no significant difference between 33 POAG participants and 20 controls (with 
minor refractive problems or presbyopia, and whose mean age was 9.1 years less 
than the POAG group) on a group of questions concerning adaptation to lighting 
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transitions and glare (P = 0.11).52 This discrepancy may result from differences in 
Likert-type scales used (five points in the Bierings et al. (2018) study versus three 
points in the Carta et al. study), differences in sample size, and/or the subject matter 
of the questions and how they were presented. 
A population-based study in Japan used frequency doubling technology (FDT) 
perimetry and a questionnaire with 10,214 participants53, of whom 447 exhibited 
visual field abnormalities (VFAs, as determined by the FDT perimetry), 227 of which 
were attributed to glaucoma. The definitive glaucomatous subgroup were 
significantly more likely to report difficulty seeing in dark places, when compared with 
visually healthy subjects (age-adjusted odds ratio = 1.55, 95% CI = 1.11–2.17, P = 
0.01).  
 
Motion perception 
No significant differences overall have been found between the performance 
of POAG and age-matched control participants in their sensitivity to motion under 
photopic and scotopic conditions.54 In photopic conditions, sensitivity to moving 
targets in both central and peripheral vision declined with age (P < 0.01). In scotopic 
conditions, sensitivity to moving targets was lower for age-matched controls and 
participants with POAG than for young controls, but only for peripheral and not for 
central vision.   
 
Object recognition 
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An experimental study has been conducted to investigate how people with 
glaucoma, relative to healthy controls, can recognise or classify common objects in 
different lighting levels.55 Visual categorization tasks were employed in two different 
contrast conditions (medium 50% and high 100%). The medium contrast setting 
aimed to simulate sub-optimal lighting conditions, such as fog, dazzling sunlight, or 
dusk or dawn light. There was no difference between the performance of glaucoma 
patients and controls when contrast was 100%. Conversely, the authors found that 
patients with glaucoma had 7% lower accuracy (P =0.046) for the medium contrast 
stimuli (87% responses correct) compared with controls (94% responses correct). 
Interestingly, object categorisation in this condition was impaired despite 
presentation of the stimuli within the intact central area of participants’ VF. This 
suggests that in many real-world situations where contrast is unlikely to be 100%, 
categorising objects may be more difficult for people with glaucoma than visually 
healthy controls, even when considering those without significant VF loss. 
Another study considered detection and categorisation of face and scene 
images among glaucoma patients with central VF defects compared to glaucoma 
patients without central VF defects in two different luminance levels.56 Two different 
contrast levels (10% and 2.5%) were used to simulate twilight conditions, lower 
levels than in the study discussed above. For scene images, there was no main 
significant main effect of the luminance contrast. However, the decrease in 
performance moving from the detection to categorisation task in the scene 
experiment was marginally greater in the 2.5% contrast condition (mean ± SD = 1.92 
± 0.96) compared to the 10% contrast (mean ± SD = 0.96 ± 0.85) for patients without 
central VF defects.  
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Use of visual aids 
Among low vision patients with sensitivity to light whose preferences for 
different light filters were assessed, over 85% of the glaucoma patients chose the 
two filters providing the greatest light transmission.57  
 
Activities of daily living (ADL) 
Ten (18%) of the 56 studies focussed on ADL. Of these, one was focussed on 
home-based modifications to lighting, four on driving, three on reading, and two on 
mobility. Seven of the 10 ADL studies were cross-sectional, and one each was a 
case-control, longitudinal and randomised control trial. These ADL studies involved a 
total of 1,674 participants.  
 
Modifying lighting in the home 
Participants with low vision (Visual acuity < 0.3 or 6/18) were randomised to 
receive standard adaptations (control group), or specific light improvements in the 
kitchen, hall and bathroom of their home over a six-month period (intervention 
group).58 Participants’ low vision resulted from several different kinds of eye disease, 
with only 5 of the 46 participants diagnosed with glaucoma. There were only 
marginal, non-significant improvements in ease of daily activities among the 
intervention group, although the intervention group’s improvement in QoL was 
significant.  
 
Driving 
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Lighting conditions can play a particularly significant role in making driving 
more difficult for people with glaucoma, irrespective of the degree of VF loss.  
Using a large dataset on activity limitation involving 293 participants with 
different types and severity of glaucoma, researchers focused in on responses to the 
driving questions, about “Driving at night”; “Driving towards oncoming headlights”; 
and “Driving towards the sun”. In contrast, more generic aspects of driving such as 
“‘Noticing when the car in front of you is speeding up or slowing down” and “Driving 
during the day” were considered the least difficult.59 
In a sub-study of the CIGTS, researchers compared the concerns of drivers 
(N = 471) and non-drivers (N = 84) living with glaucoma.60 Problems related to glare 
were the most reported, with over 50% of participating drivers experiencing “some 
difficulty” when performing tasks affected by glare. More than 20% of the 
glaucomatous drivers reported “often” or “always” having difficulty seeing the road at 
night in the rain because of headlights. The authors suggest that glare could be a 
particularly useful indicator of risk for visual problems while driving, particularly since 
glare is one of the earliest symptoms noticeable to the patient. At 54-month follow-
up, drivers with moderate-to-severe bilateral VF loss reported significantly more 
problems driving at night than drivers with mild bilateral VF loss. 
One study explored whether glaucomatous patients ceased driving 
specifically because of issues with lighting, dark adaptation and glare.61 Among 99 
participants, those with moderate or severe glaucoma were more likely to have 
discontinued driving than those with mild glaucoma (33% vs. 8%; P = 0.002), and to 
have more difficulties with dark adaptation (31% vs. 10%; P = 0.011) and glare (27% 
vs. 6%; P =0.012). Participants with self-perceived difficulty with dark adaptation or 
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glare were not statistically more likely to give up driving than those without. However, 
difficulty with dark adaptation was associated with an approximately four-fold 
likelihood of experiencing difficulty driving at night (adjusted prevalence ratio (PR) = 
3.94; P <0.0001) or experiencing difficulty in poor driving conditions (adjusted PR = 
4.09; P <0.001). Self-perceived glare was not associated with difficulty driving at 
night, but showed a marginally significant association with difficulty in poor driving 
conditions (PR = 4.17; P = 0.050).  
In a study of real-world driving performance among 21 drivers with bilateral 
moderate and advanced glaucoma (compared with 38 healthy controls), participants’ 
driving was evaluated and scored either a pass or marginal/fail.62 No difference was 
found for the glaucomatous participants who passed and failed attributable to glare 
(P = 0.88), and other psychophysical measures. The only predictor of differences 
between passing and failing glaucomatous drivers was performance on vision-
dependent psychometric tests (especially the Trail Making Test).  
 
Reading 
Three studies were included which provided some evidence of how lighting 
conditions impact upon people with glaucoma’s reading ability.  
Two studies used the Assessment of Disability Related to Vision (ADREV), a 
nine-task performance-based measure which includes one task of reading in 
reduced illumination. Evaluation of the ADREV involving 194 participants with 
glaucoma showed that reading in reduced illumination was similarly difficult to a test 
of locating objects.63 Further analysis of ADREV results from 192 glaucomatous 
participants showed that there were no statistically significant correlations between 
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any measure of VF loss and reading in reduced illumination task performance.64 
Nonetheless, an earlier version of the measure, the Assessment of Function Related 
to Vision (AFREV) had found that reading in dim light had a strong correlation with 
CS, visual acuity of the worse eye and binocular visual acuity (r = 0.68, -0.69 and -
0.67 respectively, all P < 0.01).65 
Although not formally included in the review (as it does not directly focus on 
lighting), research has shown that when letter contrast is reduced from 100% to 
20%, individuals with glaucoma read significantly more slowly than healthy controls. 
The relevant implication of this study is that increasing luminance in which people 
with glaucoma read could reduce difficulties with reading.66 
 
Mobility 
Only two included published studies focussed on mobility. However, several 
of the abstracts shown in Table 3 explore mobility in different lighting conditions, 
suggesting this to be an emerging research priority. 
One cross-sectional study used a mobility questionnaire and performance-test 
developed originally for patients with retinitis pigmentosa (RP) to assess 83 
glaucoma patients.67 Comparison of the glaucoma and RP groups’ responses 
showed that glaucoma patients reported changes in lighting at night causing more 
mobility difficulties than the RP patients. In contrast, RP patients reported more 
overall difficulty walking at night. 
A cross-sectional study nested within a larger US-based study (the Falls in 
Glaucoma Study – FIGS) considered lighting and mobility.49 Assessing fall-related 
hazards in the homes of 174 people with glaucoma, ambient lighting of <300 lux and 
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exposed light bulbs were the most frequently encountered fall-related hazards, in 
98.9% and 96% of assessed homes respectively. There was no relationship between 
VF loss and better lighting, suggesting that home lighting is often not modified even 
as glaucoma worsens, despite the low cost of this adaptation and its potential to 
reduce falls.  
 
Qualitative findings 
Two studies (4%) used qualitative data collection methods, including 
interviews and focus groups, involving a total of 44 participants living with glaucoma 
who discussed lighting-related issues in their accounts.  
In focus groups conducted in 2002, participants with glaucoma discussed 
problems related to lighting such as seeing halos, and shared advice with fellow 
group participants on how to adapt to lighting difficulties and glare; these included 
improving lighting in the home, and wearing hats outside to reduce the discrepancy 
between indoor and outdoor lighting.68   
In analysis of interviews from a more recent study, participants spoke of 
issues driving at night due to the bright lights of oncoming vehicles.69 Authors 
identified ‘the importance of lighting’ as one of their main themes impacting on 
patients’ functioning and coping behaviours. For example, some participants spoke 
of needing support particularly in dark environments – particularly when navigating 
steps or obstacles - and when transitioning between light and dark, such as entering 
the cinema. Sunlight was referred to as ‘blinding’ by one participant. Participants 
suggested that artificial lights such as daylight bulbs could help. One participant 
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found a bright light installed above her sewing machine as helpful, but felt that 
making the adaptation involved admitting to having a problem.   
 
Trends in publishing 
There has been an increase over time in published studies considering the 
impact of lighting conditions on people with glaucoma. These studies only represent 
a very small proportion of the total research in glaucoma. A PubMed search for 
articles with ‘glaucoma’ in the title yields 11726 results since the beginning of 2010 
alone; while in that same period just 29 articles (0.25%) were published that were 
relevant to lighting and included in this review.  
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Discussion 
This review shows that lighting transitions, glare and dark adaptation clearly 
present problems for both the vision and QoL of people with glaucoma. They emerge 
as some of the most consistent and frequent symptoms among people with POAG. 
Studies using the GQL-15 with large numbers of participants and in different 
geographical contexts consistently find glare and dark adaptation to be the most 
commonly problematic subscale for people with glaucoma. Yet the QoL literature 
suggests that while difficulties relating to lighting and glare are frequently expressed, 
they not perceived by patients to be the most bothersome symptoms. Indeed, 
Spaeth and colleagues suggest in a review of the glaucoma and QoL literature that a 
‘threshold’ of dark adaption and glare disability may be reached as glaucoma 
progresses, beyond which the issue ceases to increase in importance.70 Where QoL 
studies have explored associations between scores on the glare/dark adaptation 
domain and psychophysical measures, the only reliable correlation appears to be 
with CS.19 25  
Evidence regarding the impact of different lighting conditions on 
psychophysical measures and functional vision suggests that transitioning from light 
to dark or vice versa is difficult for people with glaucoma. This is also borne out by 
qualitative studies.69 Although a recent study from Bierings et al suggests that people 
with glaucoma may not strictly take longer to dark adapt than controls,42 most 
evidence suggests people with glaucoma show diminished classical dark adaptation 
than healthy aged-matched controls (AMCs).39 40 41 Bierings and colleagues’ 
questionnaire about visual performance when transitioning between different levels 
of ambient illumination also showed very large significant differences between 
glaucoma patients and AMCs.6 Nonetheless, when glaucoma patients and AMCs 
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undertake performance-based measures in non-optimal (e.g. scotopic) luminance on 
tasks such as motion perception,54 or object detection or categorisation, 55 56 the 
differences are not significant or only show small effects. A similar pattern is found in 
studies considering driving, with over 50% of glaucomatous drivers reporting 
difficulties linked to glare60 and with problems with dark adaptation associated with a 
four-times higher likelihood of difficulties with night driving.61 However when real-
world driving behaviour of glaucoma patients and age-matched controls was 
compared, glare and other psychophysical measures did not seem to affect 
performance.62 Many of the included performance-based studies have relatively 
small samples of glaucoma patients and controls, potentially limiting the statistical 
power to detect differences. 
Notably, during the literature search, it emerged that many pertinent findings 
directly considering how lighting affects ADL exist only in conference abstracts 
(Appendix 4). The focus on mobility performance in many of these abstracts 
contrasts with the fact that only two published studies included focused on 
glaucoma, lighting and mobility. It is perhaps revealing that many of these abstracts, 
either from conferences or articles currently in proof/press, are recent and focus 
more directly on lighting issues than many of the included studies which only 
consider lighting conditions incidentally (e.g. as part of a more general 
questionnaire). It could therefore be inferred that improving understanding of how 
and why glaucoma patients may have difficulties in certain lighting conditions is 
becoming more of a priority concern in glaucoma research. This is becoming more 
feasible with research facilities like HomeLab, a simulated home environment with 
automated systems allowing real-world everyday task performance in different 
lighting levels to be monitored.71 
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The included studies seldom focus specifically on adaptations and 
modifications that may help people with glaucoma cope with lighting related issues. 
However, select parts of some studies do provide some helpful insights. Nelson, 
Aspinall and colleagues suggest that simple environmental modifications can help 
diminish glare problems and avoid rapid changes in lighting levels for people with 
glaucoma.19 These include increasing brightness in dark areas (e.g. staircases), 
repainting dark walls in paler colours, installing or changing blinds or curtains, and 
considerate (re)design of window, glass and mirror areas to reduce glare. Other 
adaptations may include using dark lenses, and allowing longer for dark adaptation 
or ceasing to drive at night.25 A study from a low vision clinic suggests illuminated 
magnifiers may be useful aids, and hats with a visor and sunglasses may help 
against glare.50 Arguably, it is the fact that adaptations are simple and low-intensity 
that may explain why such frequently encountered symptoms are low priority for 
many patients.25  
Nonetheless, the review suggests that lighting issues are frequently neglected 
in the clinical management of glaucoma. Some studies indicate people with 
glaucoma are living in homes with inadequate, potentially hazardous lighting, and 
that individuals with worse VF damage do not appear to use improved lighting.48 49 
One study showed disparities in home and clinic lighting levels, showing that at least 
85% of participants with glaucoma had inadequate home lighting, and as such had 
significantly worse visual acuity and CS in their home than when measured in clinic; 
this highlights the importance of clinicians discussing lighting with their patients as a 
means of minimising visual and functional difficulties in their everyday life. Advice is 
clearly needed that is personalised to the patient with glaucoma and their affected 
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activities, for example ensuring that sufficient illumination is balanced against the 
need to minimise glare.58 
To the authors’ knowledge, this is the first systematic review to focus squarely 
on lighting, glare and dark adaptation among people with chronic forms of glaucoma. 
A review in 2011 considered therapeutic uses of lighting for older adults, but with 
only a limited focus on the specific concerns of people with eye disease.72 A 2011 
systematic review of patient-reported outcomes in glaucoma considered studies 
which had used the GQL-15, but was more focused on methodological aspects of 
the PROMs’ development and validation, rather than their thematic content.73 Many 
of the present review’s findings are supported by relevant sections of broader 
reviews on visual disability in glaucoma (see Table 3). Additionally, reviews on 
vision, ageing and age-related eye disease make clear that decreases in CS, in light 
to dark adaptation and in sensitivity to glare often occur in the healthy ageing eye 
without any underlying pathology. For example, glare has been found to cause 
significant difficulty for healthy older adults driving at night.74 However glaucoma, and 
other age-related eye diseases, such as AMD and cataracts, can clearly aggravate 
such problems. 
Table 3. Select findings relevant to lighting from key reviews 
Author(s) Year Title Select findings related to lighting  
Derby, GS 
Waite, JH 
Kirk, EB 
 
1926 Further studies on 
the light sense in 
early glaucoma75 
 
“It is our distinct impression that an examination 
of the light minimum… is of real value to us in 
making the diagnosis of early glaucoma”. 
Marlow, SB 1947 The field of vision in 
chronic glaucoma (a 
comparison of full 
with reduced 
illumination)76 
 
“The evidence presented here permits the 
conclusion that reduction of illumination is more 
than sometimes useful and that it is of definite 
value in the discovery of incipient changes as well 
as in the amplification of known or suspected 
defects”. 
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Ramulu, P 2009 Glaucoma and 
disability: which 
tasks are affected, 
and at what stage of 
disease?77 
“Difficulties related to lighting such as glare and 
difficulty adapting to different levels of light 
consistently ranked as the most frequent 
complaint… The lighting conditions under which 
tasks are performed may be even more important 
than the task itself”. 
Medeiros, FA  
Weinreb, RN 
Boer, E  
Rosen, PN 
2012 Driving Simulation 
as a Performance-
based Test of Visual 
Impairment in 
Glaucoma78 
“Increasingly challenging visual tasks on the 
[driving] simulator, under low contrast, low 
luminance conditions and performed under the 
pressure of time, could potentially reveal 
functional impairments that would not be detected 
by standard visual field assessment. This 
hypothesis remains to be investigated.” 
Nassiri, N 
Mehravaran, S 
Nouri-Mahdavi, K  
Coleman, AL 
2013 National Eye 
Institute Visual 
Function 
Questionnaire: 
Usefulness in 
Glaucoma79 
“Contrast sensitivity, glare sensitivity, and dark 
adaptation are potential items that could be 
added to the [NEI-VFQ] questionnaire to make it 
more responsive to changes in vision-related QoL 
in patients with glaucoma”. 
Wang, Y 
Alnwisi, S  
Ke, M 
2017 The impact of mild, 
moderate, and 
severe visual field 
loss in glaucoma on 
patients’ quality of 
life measured via 
the Glaucoma 
Quality of Life-15 
Questionnaire: a 
meta-analysis80 
“Glare and dark adaptation did not differ 
significantly between patients with mild and 
moderate visual field loss… glare and dark 
adaptation differed significantly between patients 
with moderate and severe glaucoma”. 
Owsley, C 
Ghate, D 
Kedar, S 
 
2018 Vision and Aging81 “Contrast sensitivity loss tends to be more severe 
in older adults who have one or more of the 
common eye chronic conditions of aging 
mentioned earlier. In glaucoma these losses are 
largely attributable to the loss of ganglion cells… 
There is also evidence suggesting that glaucoma 
impairs rod-mediated dark adaptation”. 
 
The number of studies exploring lighting in glaucoma is growing and Appendix 
4 shows several abstracts, some of which will soon be published. Nonetheless, this 
review has shown there are as yet a limited number of published studies considering 
how naturalistic, real world activities are affected by lighting conditions. The included 
studies using the ADREV and AFREV performance measures point to difficulties 
reading in low light in glaucoma, but only an aggregate measure for the task (and not 
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scores at each level of illumination) are reported. Paucity of data on how luminance 
levels affect reading among people with glaucoma contrasts markedly with AMD 
research, where the effects of differing luminance levels on reading performance has 
been explored in both cross-sectional82 and case-control83 studies. An additional 
research gap concerns how glaucoma patients’ visual acuity may change according 
to background luminance levels; in this review, only Bhorade et al (2013)48 
specifically explored glaucoma participants’ visual acuity in different lighting 
conditions. Furthermore, while there were descriptive findings regarding adaptation 
strategies, no research was identified evaluating how low vision aids, assistive 
technologies or rehabilitation initiatives may support people with glaucoma to cope 
with lighting and glare difficulties.  
Although no studies were formally excluded on the basis of insufficient quality, 
some common study limitations were identified. Only a minority of studies reported 
the treatments of the glaucomatous participants involved. When treatment status 
was reported, many patients were being treated with drops: medications that are 
associated with ocular surface changes and which may be associated with glare 
symptoms and generally reduced visual function.84 Treatment with topical beta 
antagonists and glaucoma surgery are also associated with increased cataract.85 86 
This may therefore limit the extent to which lighting issues caused by glaucoma may 
be clearly distinguished from treatment side effects and co-pathology. Studies 
employing the GQL-15 clearly suggests dark adaptation and glare are the most 
frequently encountered issue, even in early-stage glaucoma; this may not 
meaningfully reflect the clinical experience, where glaucoma is commonly seen as 
asymptomatic. This implies that there may be discrepancy between patients’ self-
reports when they consider individual isolated symptoms, and their overall visual 
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performance where lighting may have a relatively insignificant impact. Finally, there 
is heterogeneity in the definition of key concepts across studies. For example, the 
included psychophysics studies consider dark adaptation as a process taking many 
minutes, while the GQL-15 domain for dark adaptation and glare is based on items 
such as “going from a light to a dark room”, a near instantaneous process. Hence, it 
could be argued that ‘classical’ dark adaptation studies provide only partial insight 
into the underlying mechanism of glaucoma patients’ reports of disorientation when 
going from outside into a dark indoor space (e.g. a cinema). Similarly, in many of the 
included studies, distinctions between discomfort glare and disability glare are 
seldom clarified or specified. Furthermore, it is possible that the term ‘glare’ may be 
used to describe difficulty with a rapid increase in light level, or, to describe a 
dramatic loss in visual performance in the presence of backlight. The research 
landscape in lighting and glaucoma therefore appears relatively incoherent, and 
shows a gap in studies that integrate an understanding of the physiological and 
psychophysical processes with real-world clinical effects. 
There are further interesting observations about the scope of the review and 
included articles that could be interpreted as limitations. First, as the distribution of 
rods is predominant mainly outside the macular area, the studies synthesised could 
be affected by consideration of the location of the VF damage (central or peripheral). 
This kind of information was rarely stated or recorded in the studies we considered; 
many studies provided mean deviation values as an overall measure of VF loss, but 
only in a small number of cases (e.g. Wolffsohn & Cochrane) was the location of 
participants’ VF loss thoroughly described.50 The parallel here is the lack of attention 
that is often given to the actual location and spatial extent of VF loss when assessing 
impact on function in any lighting condition.5 Second, the present review has not 
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specifically considered the mechanism of early functional deficits of glare and 
adaptation in glaucoma patients. For example, it has been suggested that large (M) 
retinal ganglion cells are selectively damaged by glaucomatous optic nerve atrophy, 
and these cells are known to be particularly sensitive to luminance contrast under 
mesopic and scotopic conditions.39 40 87 Indeed, for several decades it had been 
proposed that glaucomatous loss was sensitive to stimuli that preferentially stimulate 
the magnocellular (M) ganglion cells relative to parvocellular (P) ganglion cells, 
based on the notion that M cells are selectively damaged in glaucoma.88 More recent 
evidence has contradicted this notion;89 for example, McKendrick and colleagues 
have identified foveal and midperipheral dysfunction of both M and P pathways 
among people with glaucoma.90 Third, it is important to note that the focus of this 
review is investigating the effect of different lighting conditions on real-world function 
and vision related quality of life. Thus it should be noted that a more detailed review 
of psychophysical measures, such as ERG (electroretinogram) studies, is not 
covered by our review. Fourth, none of the included studies explored in detail how 
VF measurements may be affected by lighting conditions. Conventional VF testing 
uses bright stimuli on a dark background, which may be advantageous to detect 
glaucoma; however the results may be different when patients are in a bright place in 
their daily lives. Indeed, the outcome of VF measurement may be different when 
dark stimuli, instead of bright stimuli, are used.91 
This review’s methodology also has a number of limitations. First, for the 
purposes of data extraction and quality assessment, only studies published in peer-
reviewed journals were formally included in results. This is a shortcoming not only 
because of publication bias, but also because many of the most relevant findings 
exist in a grey literature form, for example as conference abstracts (Appendix 4). 
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Second, the range of languages spoken in the review team only allowed for 
screening and inclusion of studies in English, French or Spanish (and only English 
articles were ultimately included). This meant that a fairly large number of seemingly 
relevant studies - in German (13), Japanese (5) and Russian (4) in particular - were 
therefore excluded. Third, while included studies were required to include at least 
some POAG patients, the glaucoma group in some studies involved participants with 
other forms of glaucoma (e.g. normal tension glaucoma, or secondary open-angle 
glaucoma, such as pseudoexfoliative or pigmentary glaucoma). In these studies, 
results were rarely disaggregated by exact glaucoma type, thereby limiting how 
highly specific the review’s findings are to POAG. A fourth limitation relates to using 
the assessment criteria we chose (Kmet, Lee, & Cook, 2004) for a heterogeneous 
research field. Most studies were appraised as being of high methodological quality, 
with a mean of 0.91 (out of 1) for quantitative studies and 0.83 for qualitative studies. 
However, some studies scored 1 because they elegantly replicated an existing 
questionnaire, such as the GQL-15 in a different population; while another more 
novel, complex study could score relatively low if it did not meet the precise 
assessment criteria. Additionally, the inclusion of a study from 192911 presented a 
significant challenge for using a tool that assesses quality according to modern 
scientific conventions, with the result that that study was omitted for quality 
assessment.  
In spite of these limitations, in conclusion this review provides clear evidence 
that lighting conditions may cause frequent, although not always hugely problematic, 
difficulties for the everyday visual function, QoL and daily activities of people with 
glaucoma. The weight of the evidence suggests these difficulties with lighting 
transitions and glare exceed those experienced by healthy older adults more 
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generally, and that the problems become worse as glaucoma severity increases. 
Nonetheless, tests of dark adaptation or questionnaires do not themselves allow for 
clear discrimination between people with glaucoma and visually healthy controls. 
Using naturalistic performance-based measures to assess activities of daily living 
under different lighting levels is becoming more feasible as a valuable area for 
further research. Similarly, research focussed on low vision aids and rehabilitation 
also emerges as a clear priority for future research, given both the lack of studies 
identified on this theme and the clear evidence that the majority of glaucoma 
patients’ home lighting is inadequate. Clinicians should be aware of the impacts of 
illumination on glaucoma patients and how visual function as measured in the clinic 
may not reflect their real world visual performance, especially at night or under 
scotopic conditions.  
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Appendix 1: Search terms 
Group 1: Glaucoma terms 
(glaucoma OR glaucomatous OR Glaucoma, Open-Angle {MeSH} OR POAG 
OR glaucomatous optic neuropathy {EMBASE}) 
 
AND 
 
Group 2: Lighting terms 
(lighting OR light* OR luminescen* OR "Rod-Cone interaction" OR bright* OR 
dark* OR illumina* OR photopic OR mesopic OR scotopic OR glare OR lumin* OR 
irradian* OR fluorescen* OR sunlight OR daylight OR incandescen* OR “low level 
light” OR “bright light” OR shade OR shadow OR Iridescen* OR Candela OR Lux OR 
Lumen)
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Appendix 2: Quality assessment 
Table 4. Quality assessment results from quantitative studies (N=53) 
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Altangerel et al 
(2006) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Partial (1) Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
N/A Yes 
(2) 
Yes 
(2) 
0.90 
Ansari et al 
(2002) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
1.00 
Arvind et al 
(2011) 
Yes (2) Yes (2) Yes (2) Partial (1) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.95 
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Aspinall et al 
(2005) 
Partial (1) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
N/A Yes 
(2) 
Yes 
(2) 
0.90 
Aspinall et al 
(2008) 
Yes (2) Yes (2) Partial (1) Yes (2) N/A N/A N/A Yes (2) Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
N/A Yes 
(2) 
Yes 
(2) 
0.90 
Bhorade et al 
(2013) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.95 
Bhorade et al 
(2016) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Partial (1) Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.91 
Bierings et al 
(2018)  
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Partial (1) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.91 
Bierings et al 
(2018)  
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
1.00 
Bierings et al 
(2018)  
Yes (2) Yes (2) Yes (2) Yes (2) Partial 
(1) 
N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.92 
Bierings et al 
(2019) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.95 
Brunnström et 
al (2004) 
Yes (2) Yes (2) No (0) Partial (1) Yes (2) N/A N/A Partial (1) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
No (0) Yes 
(2) 
Yes 
(2) 
0.75 
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Carta et al. 
(1998) 
Yes (2) Yes (2) Yes (2) Partial (1) N/A N/A N/A Partial (1) Partial 
(1) 
Yes 
(2) 
Partial 
(1) 
Partial 
(1) 
Partial 
(1) 
Yes 
(2) 
0.73 
Chu et al 
(2006) 
Yes (2) Yes (2) Yes (2) Partial (1) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.91 
Daruka et al 
(2018) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
N/A Yes 
(2) 
Yes 
(2) 
1.00 
Drum et al 
(1986) 
Yes (2) Yes (2) Partial (1) No (0) N/A N/A N/A Yes (2) Yes 
(2) 
Partial 
(1) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.77 
Glovinsky et al 
(1992) 
Yes (2) Yes (2) Partial (1) Partial (1) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.86 
Goldberg et al 
(2009) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.95 
Hertenstein et 
al (2016) 
Yes (2) Yes (2) Yes (2) Partial (1) N/A N/A N/A Yes (2) Partial 
(1) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.86 
Hoeft et al 
(1981) 
Partial (1) Yes (2) N/A Partial (1) N/A N/A N/A Yes (2) N/A N/A N/A N/A Partial 
(1) 
Partial 
(1) 
0.67 
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Hu et al (2014) Yes (2) Yes (2) Partial (1) Yes (2) N/A N/A N/A Yes (2) N/A Yes 
(2) 
N/A N/A Yes 
(2) 
Yes 
(2) 
0.94 
Janz et al 
(2001) 
Yes (2) Yes (2) Yes (2) Yes (2) Partial 
(1) 
N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
0.88 
Janz et al 
(2009) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
1.00 
Jost et al 
(1990) 
Yes (2) Yes (2) No (0) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.91 
Khadka et al 
(2016) 
Yes (2) Yes (2) Partial (1) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.91 
Klein et al 
(2015) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
0.91 
Kulkarni et al 
(2012) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Partial (1) Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
N/A Yes 
(2) 
Yes 
(2) 
0.90 
Kumar et al 
(2019) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
N/A Partial 
(1) 
Yes 
(2) 
0.95 
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Lahav et al 
(2011) 
Yes (2) Yes (2) Partial (1) Partial (1) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.91 
Lee et al (1998) Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
1.00 
Lee et al (2014) Yes (2) Yes (2) Partial (1) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
N/A Partial 
(1) 
Yes 
(2) 
0.90 
Lenoble et al 
(2016) 
Yes (2) Yes (2) Yes (2) Partial (1) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Partial 
(1) 
Yes 
(2) 
0.86 
Lorenzana et al 
(2009) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Partial (1) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
N/A Partial 
(1) 
Yes 
(2) 
0.90 
Mbadugha et 
al. (2012) 
Yes (2) Yes (2) Yes (2) Partial (1) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.95 
Mogil et al 
(2017) 
Yes (2) Yes (2) Yes (2) Partial (1) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Partial 
(1) 
Partial 
(1) 
0.82 
Nelson et al. 
(1999) 
Yes (2) Yes (2) Partial (1) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
N/A N/A Yes 
(2) 
Yes 
(2) 
0.94 
Nelson et al. 
(2003) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
N/A Yes 
(2) 
Yes 
(2) 
0.95 
Onakoya et al 
(2012) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
1.00 
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Roux-Sibilon et 
al (2018) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Partial 
(1) 
0.91 
Sencanic et al 
(2018) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.95 
Sherwood et al 
(1998) 
Yes (2) Yes (2) No (0) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
No (0) No (0) Yes 
(2) 
Yes 
(2) 
0.73 
Siah et al 
(2018) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
1.00 
Skalicky et al 
(2016) 
Yes (2) Yes (2) Yes (2) Partial (1) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.95 
Tam et al 
(2018) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Partial (1) Partial 
(1) 
Yes 
(2) 
N/A Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.85 
Tatemichi et al 
(2012) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.95 
Turano et al 
(2002) 
Yes (2) Yes (2) Yes (2) Partial (1) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.91 
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Velten et al 
(2001) 
Yes (2) Yes (2) Partial (1) No (0) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.82 
Willis & 
Anderson 
(2000) 
Yes (2) Yes (2) Partial (1) Partial (1) N/A N/A N/A Yes (2) Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Yes 
(2) 
Yes 
(2) 
0.90 
Wolffsohn & 
Cochrane 
(1998) 
Yes (2) Yes (2) N/A Yes (2) N/A N/A N/A N/A N/A N/A N/A N/A Partial 
(1) 
Yes 
(2) 
0.90 
Wren et al 
(2009) 
Yes (2) Yes (2) N/A Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
N/A Yes 
(2) 
Yes 
(2) 
1.00 
Yonge et al 
(2017) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Partial (1) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
0.95 
Zhou et al 
(2014) 
Yes (2) Yes (2) Yes (2) Yes (2) N/A N/A N/A Yes (2) Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
N/A Yes 
(2) 
Yes 
(2) 
1.00 
Zuege and 
Drance (1967) 
Yes (2) Yes (2) Partial (1) No (0) N/A N/A N/A Yes (2) Partial 
(1) 
Yes 
(2) 
Partial 
(1) 
N/A Yes 
(2) 
Partial 
(1) 
0.70 
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Table 5. Quality assessment results from qualitative studies (N=2) 
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Overall score  
Glen et al. 
(2015) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
0.95 
Green et al. 
(2002) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Yes 
(2) 
Partial 
(1) 
Partial 
(1) 
Yes 
(2) 
No (0) Yes 
(2) 
No (0) 0.70 
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Appendix 3: Data extraction table 
Table 6. Data extraction table.  
Frequently used abbreviations: CS = Contrast sensitivity; GQL-15 = Glaucoma Quality of life Questionnaire; NEI-VFQ-25 = National 
Eye Institute Visual Function Questionnaire; PDG - pigment dispersion glaucoma; POAG = primary open angle glaucoma; PXG – 
pseudoexfoliation glaucoma; QoL = quality of life. 
 
Authors Study title Study 
design 
Domain 
of main 
outcome 
Study objectives Study population Key outcome(s) 
measured 
Results 
Altangerel 
et al., 
2006 
Assessment 
of Function 
Related to 
Vision 
(AFREV) 
Cross-
sectional 
ADL To evaluate the 
relationship of a 
performance-
based measure of 
visual functioning 
to clinical and 
subjective 
measures in 
glaucoma 
patients. 
43 participants with 
POAG, mean (SD) 
age = 69.1 (14.3).  
Scores on a novel 
performance-based 
measure, the 
Assessment of 
Function Related to 
Vision (AFREV), 
standard clinical 
tests of visual 
function, and the 
NEI-VFQ-25.  
AFREV total scores were highly correlated with 
contrast sensitivity, binocular visual acuity, better-
eye visual acuity, worse-eye visual acuity, and 
Estermann visual field efficiency scores as well as 
with NEI-VFQ scores.  
The Rasch person-item map demonstrates that of 
AFREV activities, 
the “putting stick into holes” and “reading small 
print” tests require the most visual ability. 
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Ansari et 
al., 2002 
Psychophys
ical 
characterisa
tion of early 
functional 
loss in 
glaucoma 
and ocular 
hypertensio
n 
Case-
control 
Psychoph
ysics 
To determine 
relative damage 
to the 
magnocellular 
and parvocellular 
pathways.  
16 participants with 
early to moderate 
glaucomatous visual 
field loss (mean 
(SD) age: 68.1 
(5.1)); 16 healthy 
controls (mean (SD) 
age: 61.1 (9)); 16 
age-matched 
patients with ocular 
hypertension (mean 
(SD) age: 59.3 
(13.5)).   
Contrast sensitivity 
was for the 
detection of 
luminance 
modulated gratings 
at a range of 
spatial (0.5, 2, 8 
cycles /degree) 
and temporal (0, 16 
Hz) frequency 
combinations.  
Foveally, compared to the normal group, the 
thresholds for the glaucoma patients were 
significantly elevated at all spatial and temporal 
frequencies (p<0.0001), but this reduction was not 
significantly different at any particular spatial or 
temporal frequency (p>0.1). There was no 
difference in contrast sensitivity between the 
controls and OHTs (P > 0.10). At the periphery, 
thresholds of the glaucoma patients were 
elevated compared to the normal controls (P < 
0.01). The contrast sensitivity in normal and OHT 
groups was not significantly different (P > 0.10). 
Arvind et 
al., 2011 
Low-
Luminance 
Contrast 
Stimulation 
Is Optimal 
for Early 
Detection of 
Glaucoma 
Using 
Multifocal 
Visual 
Evoked 
Potentials 
Case-
control 
Psychoph
ysics 
To elucidate the 
mechanism 
responsible for 
the enhanced 
performance of 
the blue-on-
yellow multifocal 
visual evoked 
potential (BonY 
mfVEP) stimulus 
in identifying early 
glaucoma. 
30 healthy controls 
(mean (SD) age = 
65.1 (10.1)) and 23 
participants with 
early glaucoma 
(mean deviation 
[MD] < 6 dB ; mean 
(SD) age = 66.8 
(7.06)).   
Multifocal pattern-
onset VEPs were 
recorded in 
response to BonY, 
high-luminance 
contrast 
achromatic (HLA) 
and low-luminance 
contrast 
achromatic (LLA) 
stimulations. 
In controls, LLA mfVEPs had significantly lower 
amplitudes than did BonY and HLA mfVEPs (P < 
0.001), which were not significantly different from 
each other. In glaucomatous eyes, all three 
stimuli demonstrated significantly reduced 
amplitudes in comparison with those of normal 
eyes. Although the sensitivities of both BonY and 
LLA in identifying subjective visual field defects 
were similarly high (93% and 89.7%, 
respectively), HLA showed only a 79.3% 
detection rate. BonY and LLA demonstrated 
significantly higher defect severity scores than did 
HLA (P < 0.05 for both). Specificities for BonY 
and LLA were similar (96%). 
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Aspinall et 
al., 2005 
Quality of 
Life in 
Patients 
with 
Glaucoma: 
A Conjoint 
Analysis 
Approach 
Cross-
sectional 
Quality of 
life 
To assess the 
perceived 
importance of 
visual field loss 
on vision-related 
QoL for a group 
of patients with 
glaucoma. 
108 participants with 
glaucoma (mean 
(SD) age = 69.0 
(8.7)). 
Results on a 
battery of tests 
including clinical 
assessment, visual 
function measures, 
and QoL 
questionnaires 
(including choice-
based conjoint 
analysis).  
While problems with ‘darkness or glare’ were the 
most frequently reported complaints suffered by 
the group of subjects, their relative importance 
was much less than that assigned to the other 
attributes. Additionally, there was evidence of an 
increased priority for problems with glare as 
contrast sensitivity decreased. 
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Aspinall et 
al., 2008 
Evaluation 
of Quality of 
Life and 
Priorities of 
Patients 
with 
Glaucoma 
Cross-
sectional 
Quality of 
life 
To investigate the 
quality of life and 
priorities of 
patients with 
glaucoma. 
72 glaucoma 
patients. Mean (SD) 
age = 71.8 (11.0). 
57% of patients had 
mild VF loss, 28% 
moderate VF loss 
and 15% severe VF 
loss. 
Correlation 
between EuroQuol 
(EQ-5D), time 
tradeoff (TTO), 
and choice-based 
conjoint analysis. 
The conjoint utilities showed that the two main 
priorities were “reading and seeing detail” and 
“outdoor mobility.” A principal component analysis 
revealed relatively independent components (i.e., 
low correlations) between the three different 
methodologies for assessing quality of life. 
62 
 
Bhorade 
et al., 
2013 
Differences 
in vision 
between 
clinic and 
home and 
the effect of 
lighting in 
older adults 
with and 
without 
glaucoma. 
Case-
control 
Functional 
vision 
The purpose of 
this report was to 
1) compare vision 
between clinic 
and home and 2) 
evaluate factors, 
including lighting, 
associated with 
differences in 
vision between 
clinic and home in 
older adults with 
mild, moderate, 
and advanced 
glaucoma and no 
ocular disease. 
126 glaucoma 
patients (mean (SD) 
age = 72.5 (7.7)) 
and 49 controls with 
no glaucoma (mean 
(SD) age = 70.7 
(8.2)).  
Participants 
underwent a clinic 
and home visit 
randomized to 
order of 
completion. At 
each visit, masked 
and certified 
examiners 
measured 
binocular distance 
visual acuity (DVA) 
with a non-backlit 
chart, near visual 
acuity (NVA), 
contrast sensitivity 
(CS), CS with 
glare, and lighting.  
Main outcome 
measure was the 
difference in vision 
between clinic and 
home. 
Mean scores for all vision tests were significantly 
better in the clinic than home for glaucoma and 
non-glaucoma patients (P <0.05). For the entire 
sample, 21% of participants read ≥2 lines better in 
clinic than home for NVA and 49% read ≥2 triplets 
better in clinic for CS with glare. Lighting was the 
most significant factor associated with differences 
in vision between clinic and home for DVA, NVA, 
and CS with glare testing (p<0.05 multiple 
regression model). Median home lighting was 4.3 
times and 2.8 times lower than clinic lighting in 
areas tested for DVA and NVA, respectively. 
Home lighting was below that recommended for ≥ 
85% of participants. 
Bhorade 
et al., 
2016 
On-road 
Driving 
Performanc
e of 
Patients 
With 
Bilateral 
Moderate 
and 
Advanced 
Glaucoma 
Case-
control 
ADL To compare on-
road driving 
performance of 
patients with 
moderate or 
advanced 
glaucoma to 
controls and 
evaluate factors 
associated with 
unsafe driving. 
21 patients with 
bilateral moderate or 
advanced glaucoma 
(mean (SD) age = 
71.5 (8.5)); 38 
controls (mean (SD) 
age = 70.2 (8.4)). 
Participants 
underwent a 
clinical evaluation 
and an on-road 
driving evaluation. 
Overall driving 
performance of 
pass vs. 
marginal/fail, and 
number of wheel 
and/or brake 
52% of glaucoma participants scored a 
marginal/fail compared to 21% of controls. 
Glaucoma participants had a higher risk of wheel 
interventions than controls. There were no 
differences detected between glaucoma 
participants who scored a pass vs. marginal/fail 
for visual field mean deviation of the better or 
worse eye, binocular distance or near visual 
acuity, contrast sensitivity or glare. 
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interventions, were 
recorded. 
Bierings et 
al., 2018 
Visual 
complaints 
of patients 
with 
glaucoma 
and controls 
under 
optimal and 
extreme 
luminance 
conditions  
Case-
control  
Functional 
vision 
To determine (i) 
whether, 
compared to 
controls, visual 
complaints of 
glaucoma 
patients are more 
pronounced 
under extreme 
luminance 
conditions than in 
the optimal 
luminance 
conditions and (ii) 
whether 
complaints 
belonging to 
different extreme 
luminance 
conditions are 
associated. 
178 people with 
glaucoma (mean 
(SD) age = 72.2 
(10.0)), 182 controls 
(mean (SD) age = 
65.7 (10.8)).  
Glaucoma 
participants with 
POAG, PXG or PDG 
were eligible. 
Visual performance 
for daily activities 
under five different 
luminance 
conditions (optimal; 
low; high; sudden 
luminance 
decrease; sudden 
luminance 
increase) 
Percentages of patients and controls with visual 
complaints were 4 versus 0% (P = 0.02) for 
optimal luminance and 48 versus 6% (P < 0.001), 
22 versus 1% (P < 0.001), 32 versus 1% (P < 
0.001) and 25 versus 3% (P < 0.001) for low, 
high, sudden decrease and sudden increase in 
luminance.  
Bierings et 
al., 2018 
Visual 
Performanc
e as a 
Function of 
Luminance 
in 
Glaucoma: 
The De 
Vries-Rose, 
Weber's, 
and Ferry-
Case-
control 
Psychoph
ysics 
To determine 
whether the De 
Vries-Rose, 
Weber’s, and 
Ferry-Porter’s 
law, which 
describe visual 
performance as a 
function of 
luminance, also 
19 participants with 
glaucoma (median 
(IQR) age = 71 (64-
73)), 45 controls 
(median (IQR) age = 
54 (47-65)). 
  
Foveal and 
peripheral CS, and 
foveal and 
peripheral critical 
fusion frequency 
(CFF) as a function 
of luminance (0.02 
to 200 cd/m2).  
Foveally, glaucoma patients had a 0.4 log unit 
lower logCS than controls (P < 0.001), 
independent of luminance. Peripherally, the 
difference was more pronounced at lower 
luminances (P = 0.007). Glaucoma patients had a 
lower CFF compared with controls (P < 0.001). 
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Porter's 
Law 
apply to patients 
with glaucoma. 
Bierings et 
al., 2018 
Foveal light 
and dark 
adaptation 
in patients 
with 
glaucoma 
and healthy 
subjects: A 
case-control 
study 
Case-
control  
Psychoph
ysics 
To determine 
whether foveal 
light and dark 
adaptation are 
affected in 
glaucoma. 
23 participants with 
glaucoma (median 
(IQR) age = 69 (61-
73)) and two 
different groups of 
controls. 51 controls 
for 5 log unit step 
condition (median 
(IQR) age = 57 (49-
65)) and 52 controls 
for 6.5 log unit step 
condition (median 
(IQR) age = 58 (49-
66)). 
Light and dark 
adaptation were 
measured twice. 
After 10 minutes 
pre-adaptation to 
0.0032 cd/m2, the 
background 
luminance 
increased stepwise 
to 320 (5 log unit 
step) or 10,000 
cd/m2 (6.5 log unit 
step) for 
10 minutes, then it 
decreased back to 
0.0032 cd/m2 for 
30 minutes. Foveal 
contrast sensitivity 
[CS]) as a function 
of time was 
determined. 
After light adaptation to 320 and 10,000 cd/m2, 
glaucoma patients had a 0.22 (P < 0.001) and 
0.13 (P = 0.010) log unit lower CS plateau than 
controls, respectively. After dark adaptation, this 
difference was 0.21 (P = 0.018) and 0.30 
(P<0.001) log unit, respectively. Light 
adaptation occurred too fast to determine an 
accurate light adaptation time. Dark adaptation 
times of glaucoma patients and controls were 
similar, for both the 5 (7.2 versus 5.5 minutes; P = 
0.10) and the 6.5 (18.2 versus 16.6 minutes; P = 
0.14) log unit step conditions. 
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Bierings et 
al., 2019 
Spatial 
contrast 
sensitivity 
from star- to 
sunlight in 
healthy 
subjects 
and patients 
with 
glaucoma 
Case-
control 
Psychoph
ysics 
The aims of this 
study were (i) to 
determine 
whether Weber’s 
law also holds 
under extremely 
high luminance 
conditions and 
how this depends 
on spatial 
frequency, and (ii) 
to compare CS as 
a function of 
spatial frequency 
and luminance 
between 
glaucoma 
patients and 
healthy subjects. 
22 people with 
glaucoma (median 
(IQR) age = 68 (60-
73)), 51 controls 
(median (IQR) age = 
58 (49-66)). 
Monocular contrast 
sensitivity (CS) at 
1, 3, and 10 cycles 
per degree (cpd); 
mean luminance 
ranged from 
0.0085 to 8500 
cd/m2. Authors 
analysed the effect 
of glaucoma, 
luminance, and 
spatial frequency 
on logCS.  
The logCS versus log luminance curves did not 
differ grossly between patients and controls 
(P=0.14; typically 0–0.2 log units); the difference 
became larger with decreasing luminance 
(P=0.003) but did not depend clearly on spatial 
frequency (P=0.27). 
Brunnströ
m et al., 
2004 
Quality of 
light and 
quality of 
life–the 
effect of 
lighting 
adaptation 
among 
people with 
low vision 
Randomi
sed 
controlle
d trial 
ADL The study has 
investigated the 
effect of lighting 
on the daily 
activities (ADL) of 
the visually 
impaired in their 
homes by 
comparison 
before and after 
light adjustments 
were made in the 
kitchen, hall and 
bathroom. It has 
also investigated 
the additional 
46 test subjects who 
were visually 
impaired (VA ≤ 0.3) 
and were from five 
diagnostic groups: 
macular 
degeneration, dry 
form (n = 12), 
macular 
degeneration, wet 
form (n = 16), 
retinitis pigmentosa 
(n = 2), glaucoma 
(n= 5), other 
diagnoses (n =11). 
Lighting standards 
and psychosocial 
factors were 
charted. 
Participants were 
randomly divided 
into two groups, an 
intervention and a 
comparison group. 
Follow-up 
interviews to 
determine ADL and 
quality of life were 
performed 6 
months after 
lighting adaptation. 
A marked effect on quality of life of the lighting in 
the living room was found for the intervention 
group. The effect on ADL of the basic lighting 
adaptation in kitchen, hall and bathroom for both 
groups was significant for tasks carried out on the 
working surface in the kitchen. Other activities in 
the kitchen and in the bathroom tended to 
improve but changes were not significant. 
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effects on the 
quality of life after 
providing task 
lighting in the 
living room. 
Carta et 
al., 1998 
Self-
assessment 
of the 
quality of 
vision: 
association 
of 
questionnair
e score with 
objective 
clinical tests 
Cross-
sectional 
Functional 
vision 
To investigate the 
association of a 
quality of life 
visual function 
questionnaire 
with an objective 
clinical test of 
visual function. 
120 participants with 
different eye 
diseases (33 with 
POAG). Mean (SD) 
age overall was 65.8 
(10.1), and mean 
(SD) age for POAG 
participants was 
65.4 (11.3). 
Questionnaire 
scores, and their 
association with 
results of 
psychophysical 
tests commonly 
used in clinical 
practice to assess 
visual function. 
The total questionnaire score was significantly 
associated with the results of all visual function 
tests with the exception of glare.  
Chu et al., 
2006 
Glaucoma 
Detection Is 
Facilitated 
by 
Luminance 
Modulation 
of the 
Global 
Flash 
Multifocal 
Electroretin
ogram 
Case-
control 
Psychoph
ysics 
To investigate the 
variation of retinal 
electrophysiologic
al function in 
glaucoma by 
using the global 
flash multifocal 
electroretinogram 
(mfERG) 
stimulation with 
altered 
differences in the 
stimulus 
luminance of the 
multifocal flashes, 
in an attempt to 
alter the levels of 
30 healthy 
participants (mean 
(SD) age = 36.9 
(12.2)); 30 POAG 
participants (mean 
(SD) age = 39.4 
(11.5)). 
The mfERG was 
assessed with a 
visual stimulus in 
steps of four video 
frames, which 
consisted of 103 
scaled hexagonal 
elements followed 
by a dark frame, 
global flash, and 
dark frame. The 
localized 
luminance 
difference was set 
at 96%, 65%, 49%, 
or 29% stimulus 
contrast. 
This stimulus induces complex local first-order 
responses with an early direct component (DC) 
and a later induced component (IC). An “adaptive 
index” was calculated from the luminance-
difference dependence of the peripheral DC, and 
it showed a sensitivity of 93%, with a specificity of 
95% for differentiating normal from glaucomatous 
eyes, and also had a significant correlation (r = 
0.58) with the glaucomatous visual field defect. 
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inner retinal 
contributions. 
Daruka et 
al., 2018 
Correlation 
of central 
field index 
(10-2 visual 
field 
analysis) 
and activity 
limitation 
with 
increasing 
severity of 
glaucoma 
using 
glaucoma 
activity 
limitation-9 
questionnair
e. 
Cross-
sectional 
Quality of 
life 
To investigate the 
relationship 
between 
vision-related 
QoL, as 
measured by the 
GAL-9 
questionnaire, 
and the central 
field index (CFI) 
in patients with 
advanced 
glaucoma. 
50 glaucoma 
patients (mean (SD) 
age = 63.54 
(12.35)).  
Correlation 
between the CFI 
and the GAL-9 
scores. 
There was a moderate correlation between CFI of 
better eye (r = −0.431, confidence interval “CI” 
−0.619 to −0.173, P < 0.002) and worse eye (r = 
−0.342, CI: −0.575 to − 0.058, P < 0.015) with 
GAL-9, the better eye showing a stronger 
correlation. Subscales of GAL-9 questionnaire 
also correlated with better eye status. “Finding 
dropped objects” had the strongest correlation to 
CFI of better eye (r = −0.676) and “adjusting to 
dim lights” had the weakest correlation (r = 
−0.052). 
Derby et 
al., 1929 
The light 
sense in 
early 
glaucoma: 
the smallest 
difference in 
brightness 
perceptible 
to the light 
adapted 
eye (light 
difference).  
Case-
control 
Psychoph
ysics 
To investigate the 
ability of the eye 
to detect a 
difference in the 
degree of 
brightness to 
discover if this 
might be 
significant as a 
diagnostic sign in 
early glaucoma.  
89 participants with 
suspected 
glaucoma; 29 
controls; 38 
participants with 
established 
glaucoma. All in the 
age range 50-70 
years. 
Dark adaptation 
readings among 
people with 
glaucoma and 
healthy controls.  
The smallest perceptible increase in brightness 
was 2 per cent for clinical group 1 (healthy eyes, 
no sign of glaucoma), 2.8% for group 2, 3% for 
group 3, 3.5% for group 4, 6.1% for group 5 and 
6.5% for group 6 (advanced glaucoma). There 
was wide variation in readings of light difference 
percentages in each clinical group and much 
overlapping between the groups.  
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Drum et 
al., 1986 
Scotopic 
Sensitivity 
Loss in 
Glaucoma 
Case-
control 
Psychoph
ysics 
To compare 
measurements of 
photopic and 
scotopic 
sensitivity for 
patients with 
open angle 
glaucoma, 
patients 
suspected of 
having glaucoma  
and normal 
control subjects 
at six selected 
positions in the 
nasal visual field.  
31 healthy control 
participants (10 
under 40, 15 in 40-
60 range, 6 over 60); 
39 participants with 
suspected glaucoma 
(6 under 40, 22 in 
40-60 range, 11 over 
60); 
39 participants with 
confirmed open 
angle glaucoma (6 
under 40, 17 in 40-
60 range, 16 over 
60). 
Photopic and 
scotopic thresholds 
at three 
eccentricities (5◦, 
10◦ and 15◦). 
Both photopic and scotopic thresholds were 
elevated significantly for both the suspect and 
glaucoma groups. The average photopic and 
scotopic threshold elevations were the same for 
the suspect group, but scotopic threshold 
elevations were substantially greater than 
photopic threshold elevations for the glaucoma 
group.  
Glen et 
al., 2015 
Living with 
glaucoma: a 
qualitative 
study of 
functional 
implications 
and 
patients’ 
coping 
behaviours 
Qualitativ
e 
Qualitative This study aimed 
to identify 
different 
strategies used 
by patients with 
glaucoma to cope 
with vision loss 
during everyday 
activities. 
16 participants living 
with glaucoma 
(median (IQR) age = 
71 (68 – 77)). 
Different strategies 
used by patients 
with glaucoma to 
cope with vision 
loss during 
everyday activities. 
In order to maintain independence, some patients 
increased confidence by making practical 
changes such as adjusting lighting, using 
handrails and magnifying glasses, or actively 
changed aspects of their behaviour such as 
moving their head and eyes towards known areas 
of vision loss.  
Glovinsky 
et al., 
1992 
A Whole-
Field 
Scotopic 
Retinal 
Sensitivity 
Test for the 
Detection of 
Early 
Case-
control 
Psychoph
ysics 
Evaluate a new 
psychophysical 
test that utilises a 
whole-field light 
stimulus under 
dark-adapted 
conditions.  
35 healthy 
participants; 21 
participants with 
glaucoma; 77 
glaucoma-suspect 
participants. All were 
over 35.  
Four retinal 
sensitivity 
measurements - 
one absolute 
retinal sensitivity 
(ARS) and three 
incremental retinal 
sensitivities. 
Glaucomatous eyes were discriminated from 
normal with a diagnostic power of 0.91 as judged 
by receiver operating characteristic analysis, and 
specificity and sensitivity were 91% and 86%, 
respectively. Glaucoma suspects with an 
abnormal response to the whole-field scotopic 
test were more likely to have other signs 
indicating early optic nerve injury.  
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Glaucoma 
Damage 
Goldberg 
et al., 
2009 
Assessing q
uality of 
life in patien
ts with glau
coma using 
the Glauco
ma Quality 
of Life-15 
(GQL-15) 
questionnair
e. 
Case-
control 
Quality of 
life 
To measure and 
compare quality 
of life in patients 
with and without 
glaucoma using 
the Glaucoma 
Quality of Life-15 
Questionnaire, 
and to determine 
the association 
between 
glaucoma-related 
quality of life and 
clinical indices of 
glaucoma. 
121 participants with 
glaucoma (mean 
(SD) age = 70 (9.1)) 
and 31 control 
participants (mean 
(SD) age = 63 (8.9)). 
Of the glaucomatous 
participants, 49 had 
mild, 34 moderate, 
and 38 severe 
glaucoma. 
GQL-15 scores, 
and the 
relationship 
between the 
likelihood of 
reporting vision-
related dysfunction 
and glaucoma 
severity. 
Patients with glaucoma had significantly poorer 
glaucoma-related quality of life than controls 
(P<0.001). Summary scores differed significantly 
among patients with mild, moderate, and severe 
glaucoma demonstrating a trend of poorer quality 
of life with increasing disease severity. Activities 
involving glare and dark adaptation were most 
problematic for all, but patients with glaucoma felt 
significantly more compromised in central and 
near vision, peripheral vision, and outdoor 
mobility (all P < 0.001). 
Green et 
al., 2002 
Learning to 
live with 
glaucoma: a 
qualitative 
study of 
diagnosis 
and the 
impact of 
sight loss 
Qualitativ
e 
Qualitative To identify 
triggers to self-
referral for 
glaucoma 
symptoms in a 
UK sample from 
Britain, and to 
explore the 
meaning of 
symptoms for 
people living with 
moderate to 
severe glaucoma. 
28 participants with 
moderate or severe 
open-angle 
glaucoma.  
Different kinds of 
experiences 
discussed, 
including lighting 
and glare.  
Participants reported low levels of awareness of 
glaucoma prior to their diagnosis, and had 
assumed that symptoms were the ‘normal’ 
deterioration of eyesight expected with other 
morbidity or advancing age. Participants reflected 
on problems with light and seeing ‘halos’ around 
lights as one of the possible early symptoms.  
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Hertenstei
n et al., 
2016 
Marked 
dissociation 
of photopic 
and 
mesopic 
contrast 
sensitivity 
even in 
normal 
observers 
Case-
control 
Psychoph
ysics 
To investigate if 
photopic CS can 
act as a surrogate 
measure for 
mesopic CS, 
potentially for 
screening 
purposes. 
47 healthy controls, 
23 participants with 
glaucoma, and 3 
participants with 
cataract. No age 
means were 
reported. Age 
ranges were: 
Controls 20–61, 
glaucoma 37–80, 
cataract 63–76. 
Photopic contrast 
sensitivity, 
assessed with both 
the Freiburg Acuity 
and Contrast Test 
(FrACT) and the 
Mars Letter 
Contrast Sensitivity 
Charts. Mesopic 
contrast sensitivity, 
without and with 
glare, was 
measured with the 
Mesoptometer IIb.  
While mesopic and photopic contrast sensitivities 
correlate significantly (r = 0.51, P <0.01), only 27 
% of the variance is in common. In particular, 
subjects with high photopic results may be nearly 
as likely to have low as well as high mesopic 
results. 
Hoeft et 
al., 1981 
A 
comparative 
study of 
low-vision 
patients: 
Their ocular 
disease and 
preference 
for one 
specific 
series of 
light 
transmissio
n filters 
Descripti
ve case 
series 
Functional 
vision 
Find out eye 
disease patients' 
preferences for 
light filters. 
100 low vision 
patients with 
sensitivity to light, of 
whom 13 had 
glaucoma. The 100 
patients ranged from 
18 to 80 years, with 
majority in 42-61 
range. No means, or 
age data for the 
glaucoma group. 
Filter preference 
out of 5 filters. 
More than 85% of glaucoma patients chose the 
two filters with the greatest light transmission.  
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Hu et al., 
2014 
What Do 
Patients 
With 
Glaucoma 
See? Visual 
Symptoms 
Reported by 
Patients 
With 
Glaucoma 
Cross-
sectional 
Functional 
vision 
To improve 
understanding of 
how glaucoma 
affects vision 
from the patients’ 
point of view by 
asking specific 
detailed 
questions about 
how they see. A 
secondary 
objective of the 
study was to 
correlate severity 
of VF loss with 
visual symptoms 
reported. 
99 glaucoma 
patients. 47 with 
early glaucoma 
(mean (SD) age = 
67 (13)); 26 with 
moderate glaucoma 
(mean (SD) age = 
76 (13); 14 with 
advanced glaucoma 
(mean (SD) age = 
68 (10)); 7 with 
severe glaucoma 78 
(14); 5 with end-
stage glaucoma 
(mean (SD) age = 
81 (13)). 67% with 
POAG. 
Most common 
visual symptoms 
reported by all 
patients, and any 
association 
between glaucoma 
severity and visual 
symptoms 
reported. 
The most common symptoms reported by all 
patients, including patients with early or moderate 
glaucoma, were needing more light and blurry 
vision. Patients with a greater amount of field loss 
(Octopus mean defect .+9.4 dB) were more likely 
to report difficulty seeing objects to one or both 
sides, as if looking through dirty glasses and 
trouble differentiating boundaries and colours. 
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Janz et 
al., 2001 
Quality of 
life in newly 
diagnosed 
glaucoma 
patients: 
The 
Collaborativ
e Initial 
Glaucoma 
Treatment 
Study 
Cross-
sectional 
Quality of 
life 
To describe the 
QoL 
measurement 
approach of the 
Collaborative 
Initial Glaucoma 
Treatment Study, 
instruments 
included, and the 
CIGTS 
participants’ QoL 
findings at the 
time of diagnosis. 
607 patients with 
glaucoma. 147 
(24.2%) in the 29–49 
age range,  
269 (44.3%) in the 
50–64 age range, 
and 191 (32.5%) in 
the 65–75 age 
range.   
Quality of life, 
incorporating both 
disease-specific 
and generic 
measures. 
The correlations between QoL measures and 
clinical outcomes were in the expected direction, 
but relatively weak. At initial diagnosis, difficulty 
with bright lights and with light and dark 
adaptation were the most frequently reported 
symptoms related to visual function, whereas 
visual distortion was the most bothersome.  
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Janz et 
al., 2009 
Evaluating 
Clinical 
Change and 
Visual 
Function 
Concerns in 
Drivers and 
Nondrivers 
with 
Glaucoma 
Longitudi
nal 
ADL To compare 
drivers and 
nondrivers, and to 
describe the 
specific concerns 
of drivers, among 
individuals with 
glaucoma. 
471 drivers and 84 
nondrivers, all with 
glaucoma.  
Age ranges: 
25–49: Drivers 119 
(25.3%), non-drivers 
12 (14.3%) 
50–64: Drivers 198 
(42.0%), non-drivers 
42 (50.0%) 
65–74: Drivers 149 
(31.6%), non-drivers 
28 (33.3%) 
Driving status 
(drivers versus 
non-drivers) and 
patient-reported 
visual function, as 
determined by the 
Visual Activities 
Questionnaire and 
the National Eye 
Institute Visual 
Function 
Questionnaire.  
More than 50% of drivers reported at least “some” 
difficulty performing tasks involving glare, 
whereas 22% reported at least “some” difficulty 
with tasks requiring peripheral vision. At 54 
months, drivers with moderate/severe bilateral 
visual field loss (VFL) reported greater difficulty 
with night driving and tasks involving visual 
search and visual processing speed than drivers 
with less bilateral VFL (all P < 0.05).  
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Jonas et 
al., 1990 
Dark 
adaptation 
in 
glaucomato
us and 
nonglaucom
atous optic 
nerve 
atrophy 
Case-
control 
Psychoph
ysics 
To evaluate dark 
adaptation in 
healthy 
participants and 
patients with optic 
nerve damage, 
and compare for 
differences 
between the 
groups. 
14 healthy control 
participants (mean 
(SD) age = 37.7 
(19.6)); 19 patients 
with POAG (mean 
(SD) age = 57.4 
(14.4)); 4 patients 
with non-
glaucomatous 
descending optic 
nerve atrophy (mean 
(SD) age = 32.7 
(11.4)).  
Dark adaptation 
threshold, 
evaluated for each 
eye separately. 
In the healthy participants, light thresholds and 
time of the shoulder in the dark adaptation curve 
increased significantly with age. In eyes with 
glaucomatous or nonglaucomatous optic nerve 
damage light sensitivity was lower than in normal 
eyes of age-matched control groups.  
Khadka et 
al., 2016 
Item 
Banking 
Enables 
Stand-
Alone 
Measureme
nt of Driving 
Ability 
Cross-
sectional 
ADL To explore 
whether large 
item sets, as 
used in item 
banking, enable 
important latent 
traits, such as 
driving, to form 
stand-alone 
measures. 
293 participants with 
glaucoma. Median 
age = 71 (range = 
21-93 years). 54.5% 
of participants had 
POAG. Other 
included glaucoma 
types were angle 
closure glaucoma; 
PXF and normal-
tension glaucoma. 
The 88-item activity 
limitation (AL) 
domain of the 
glaucoma module 
of the Eye-tem 
Bank was 
interviewer 
administered to 
patients with 
glaucoma.  
These findings indicate that driving items in the 
AL domain of the glaucoma module were 
perceived and responded to differently from the 
other AL items, but the reading and luminance 
items were not. Therefore, item banking 
enables stand-alone measurement of driving 
ability in glaucoma. 
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Klein et 
al., 2015 
The Effect 
of Cataract 
on Early 
Stage 
Glaucoma 
Detection 
Using 
Spatial and 
Temporal 
Contrast 
Sensitivity 
Tests 
Case-
control 
Psychoph
ysics 
To investigate the 
effect of cataract 
on the ability of 
spatial and 
temporal contrast 
sensitivity tests 
used to detect 
early glaucoma. 
27 glaucoma 
participants with 
early cataract (mean 
(SD) age = 60 
(10.2)) which 
constituted the test 
group were recruited 
together with 27 
controls (cataract 
only) (mean (SD) 
age = 59.03 (9.0)).  
Contrast sensitivity 
to flickering 
gratings at 20 Hz 
and stationary 
gratings with and 
without glare, were 
measured for 0.5, 
1.5 and 3 cycles 
per degree (cpd) in 
central vision. 
Perimetry and 
structural 
measurements with 
the Heidelberg 
Retinal Tomograph 
(HRT) were also 
performed. 
After considering the effect of cataract, contrast 
sensitivity to stationary gratings was reduced in 
the test group compared with controls with a 
statistically significant mean difference of 0.2 log 
units independent of spatial frequency. A 
significant correlation was found between the 
reduction of contrast sensitivity caused by glare 
and the Glaucoma Probability Score (GPS) as 
measured with the HRT (P <0.005). 
Kulkarni et 
al., 2012 
Visual Field 
Staging 
Systems in 
Glaucoma 
and the 
Activities of 
Daily Living 
Cross-
sectional 
ADL To compare 8 
clinically relevant 
methods of 
staging visual 
field (VF) damage 
in glaucoma with 
a performance-
based measure of 
the activities of 
daily living and 
self-reported 
quality of life. 
192 glaucoma 
patients, mean (SD) 
age = 67.1 (12.9). 
140 (72.9%) of the 
sample had POAG.  
Results from visual 
field tests, ADREV 
scores and NEI-
VFQ-25 scores.  
ADREV scores and NEI-VFQ-25 scores were 
associated most closely with the VF score in the 
better eye and the binocular VF scoring systems. 
Kumar et 
al., 2019 
The impact 
of primary 
open-angle 
glaucoma: 
Comparison 
of vision-
Cross-
sectional 
Quality of 
life 
To compare a 
general vision-
specific patient-
reported 
outcomes (PRO) 
instrument, 
140 participants with 
POAG. 49 with mild 
POAG (mean (SD) 
age = 60.15 (7.45)), 
55 with    
This study was 
designed to 
compare two 
disease-specific 
instruments (GQL-
15 and 
There was a statistically significant difference 
between patients with mild, moderate, and severe 
POAG with all instruments (P ≤ 0.001). The 
instruments correlated well across several 
parameters especially the peripheral vision and 
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specific 
(National 
Eye 
Institute 
Visual 
Function 
Questionnai
re-25) and 
disease-
specific 
(Glaucoma 
Quality of 
Life-15 and 
Viswanatha
n 10) 
patient-
reported 
outcome 
(PRO) 
instruments. 
National Eye 
Institute Visual 
Function 
Questionnaire-25 
(NEIVFQ-25) with 
two disease-
specific PRO 
instruments, 
Glaucoma Quality 
of Life-15 (GQL-
15), and 
Viswanathan 10 
in patients with 
varying severity 
of primary open 
angle glaucoma 
(POAG) 
moderate POAG 
(mean (SD) age = 
62.65 (8.13)), 36 
with severe POAG 
(mean (SD) age = 
62.53 (6.12)).   
Viswanathan 10) 
with one vision-
specific instrument 
(NEIVFQ-25) for 
QoL assessment in 
Indian POAG 
patients. 
glare/dark adaptation. The disease-specific scales 
however are simpler and faster to administer. 
Lahav et 
al., 2011 
Reduced 
Mesopic 
and 
Photopic 
Foveal 
Contrast 
Sensitivity 
in 
Glaucoma 
Case-
control 
Psychoph
ysics 
To demonstrate 
differences in 
foveal constrast 
sensitivity (CS) 
between 
glaucomatous 
and 
nonglaucomatous 
eyes using a 
simple, rapid 
computerized 
test. 
27 participants with 
glaucoma (mean 
(SD) age = 64.4 
(9.9)) and 23 control 
participants (mean 
(SD) age = 62.6 
(10.6)). 
Contrast sensitivity 
(CS), examined by 
means of 2 
computerized 
psychophysical 
tests. The tests 
were conducted 
under photopic and 
mesopic 
conditions. 
Significantly lower foveal CS was found in 
glaucomatous eyes under photopic and mesopic 
conditions for all spatial frequencies (P < .01). All 
transient photopic and mesopic CSs were 
significantly correlated with cup to disc ratio (P < 
.05). The static photopic spatial frequency of 6 
cycles per degree was significantly correlated with 
the severity of the glaucomatous damage. 
Lee et al., 
1998 
The 
Glaucoma 
Symptom 
Case-
control 
Quality of 
life 
To develop a brief 
symptom survey 
specific for 
147 participants with 
glaucoma among a 
broad range of 
A modified version 
of the Ocular 
Hypertension 
The GSS has 2 underlying domains that 
demonstrate sufficient internal consistency 
reliability for between-group comparisons. The 
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Scale: A 
Brief Index 
of 
Glaucoma-
Specific 
Symptoms 
persons with 
glaucoma, the 
Glaucoma 
Symptom Scale. 
treatment categories 
and 44 controls. 
Average age of 
glaucoma patients 
was 64 years and 
average age of 
controls was 49 
years. 
Treatment Study 
10-item symptom 
checklist. 
Participants also 
completed 2 vision-
specific measures, 
the NEI-VFQ and 
the VF-14.  
GSS discriminates well between persons with and 
without glaucoma. 120 of the glaucomatous 
participants (82%) reported problems seeing in 
the dark, versus 14 (32%) participants in the 
control group. 
Lee et al., 
2014 
The 
association 
between 
clinical 
parameters 
and 
glaucoma-
specific 
quality of 
life in 
Chinese 
primary 
open-angle 
glaucoma 
patients. 
Cross-
sectional 
Quality of 
life 
To investigate the 
correlations 
between clinical 
parameters and 
glaucoma-specific 
QoL in Chinese 
patients with 
bilateral POAG. 
51 POAG patients, 
with varying degrees 
of glaucoma 
severity. Mean (SD) 
age = 65.8 (12.1) 
years. 
Scores on a 
Chinese translation 
of the Glaucoma 
Quality of Life–15 
questionnaire, and 
clinical parameters 
(e.g. visual field, 
best-corrected 
visual acuity, IOP, 
RNFL thickness, 
and the number of 
topical anti-
glaucoma 
medications being 
used. 
There was a significant correlation and linear 
relationship between a poorer Glaucoma Quality 
of Life–15 score and a lower visual field index (r = 
0.3, r2 = 0.1, P = 0.01) and visual acuity (r = 0.3, r2 
= 0.1, P = 0.03). The three most problematic 
activities affecting quality of life were “adjusting to 
bright lights”, “going from a light to a dark room or 
vice versa”, and “seeing at night”. 
Lenoble et 
al., 2016 
Visual 
object 
categorisati
on in people 
with 
glaucoma 
Case-
control 
Functional 
vision 
To determine 
whether 
glaucoma affects 
the ability to 
categorise briefly 
presented visual 
objects in central 
vision. 
14 people with 
glaucoma (POAG 
and pre-perimetric), 
mean (SD) age = 68 
(7); and 15 age-
matched controls, 
mean (SD) age = 66 
(5).  
Visual 
categorisation 
performance, 
assessing both 
accuracy and 
response times.  
On average, accuracy was significantly 
decreased by 7% (P =0.046) for the medium 
contrast stimuli in patients with glaucoma 
compared with controls. Group average response 
times were significantly slower for the patients 
relative to the control group. Performance was 
equivalent in the two groups when the picture 
contrast was 100%. 
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Lorenzana 
et al., 
2009 
A New 
Method of 
Assessing 
Ability to 
Perform 
Activities of 
Daily Living: 
Design, 
Methods 
and 
Baseline 
Data 
Cross-
sectional 
ADL To determine the 
relationship 
between ADREV 
(Assessment of 
Disability Related 
to Vision) 
evaluations and 
both clinical and 
subjective 
measures in 
glaucoma 
patients. 
194 glaucoma 
patients, mean (SD) 
age = 67.1 (12.9). 
140 (72.2%) of the 
sample had POAG.  
Performance on 
the ADREV, which 
includes nine tasks 
to simulate daily 
living activities, and 
scores on the NEI-
VFQ-25. 
While ADREV score ranges from 0 (total 
disability) to 63 (no disability), total ADREV score 
ranged from 3.0 to 61.7. Total NEI VFQ-25 score 
ranged from 17.8 (low score indicates incapable) 
to 100 (high score indicates not hindered). 
Mbadugha 
et al., 
2012 
 
A 
comparison 
of the NEI-
VFQ-25 and 
GQL-15 
questionnair
es in 
Nigerian 
glaucoma 
patients. 
Case-
control 
Quality of 
life 
To compare two 
vision-specific 
QoL instruments 
– the disease-
specific 15-item 
Glaucoma Quality 
of Life 
questionnaire 
(GQL-15) and the 
non glaucoma-
specific 25-item 
National Eye 
Institute Visual 
Function 
Questionnaire 
(NEI-VFQ-25). 
132 glaucoma 
participants and 132 
controls. Mean age 
was 52.81 for 
participants with mild 
glaucoma (N= 44), 
59.11 for 
participants with 
moderate glaucoma 
(N = 44) and 62.67 
for participants with 
severe glaucoma (N 
= 44). 
The range, mean, 
median, and 
standard deviation 
of QoL scores for 
the two 
questionnaires 
were calculated 
and compared for 
the subgroups of 
participants. 
Spearman’s rank 
correlation 
coefficients were 
used to assess the 
correlation 
between the GQL-
15 and the NEI-
VFQ-25. 
Patients had the greatest difficulty with activities 
affected by glare and dark adaptation in the GQL-
15. Driving and general vision were the factors 
most affected in the NEI-VFQ-25. The Spearman 
rho values showed strong correlations (rho: 0.55) 
between the NEI-VFQ-25 and GQL-15 QoL 
scores for the total number of participants (rho: 
−0.75), total number of cases (rho: −0.83), and 
the mild (rho: -0.76), moderate (rho: −0.75), and 
severe (rho: −0.84) cases.  
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Mogil et 
al., 2017 
Glaucoma 
Patient–
Reported 
Concerns 
and 
Associated 
Factors 
Cross-
sectional 
Quality of 
life 
To assess the 
character and 
degree of 
concerns of 
glaucoma 
patients and 
identify 
demographic/clini
cal factors 
affecting the 
concerns. 
 152 participants 
with glaucoma 
(mean (SD) age = 
69 (14)). 97 
participants with 
POAG, 18 with 
exfoliation 
glaucoma, 4 with 
pigmentary 
glaucoma, and 33 
with chronic angle-
closure glaucoma. 
Severity of 
concerns, scored 
with a scale of 0–5 
(in order of 
increasing 
severity). 
Severity of concern was greatest for general 
eyesight (2.92/5.00) and visual symptoms 
(2.78/5.00), followed by activities (2.20/5.00) and 
socioeconomic factors (2.13/5.00), and then 
ocular symptoms (1.69/5.00) (P < .001). The most 
common concerns within each domain were 
blurry vision (32%), reading small print (34%), 
medical costs (26%), and dryness (32%). 
Nelson et 
al., 1999 
Patients’ 
perception 
of visual 
impairment 
in 
glaucoma: a 
pilot study 
Cross-
sectional 
Quality of 
life 
To identify the 
most commonly 
perceived 
disabilities in the 
daily life of 
glaucoma 
patients by 
means of a 
questionnaire, to 
rank the 
perceived 
problems with 
regard to 
frequency, to 
group related 
visual problems 
and assess their 
impact on daily 
life activities, and 
to examine the 
relation between 
perceived visual 
difficulties and the 
63 glaucoma 
patients (mean (SD) 
age = 70 (14) years). 
80% of participants 
had POAG, while 
the remaining 20% 
had other chronic 
types of glaucoma 
such as normal-
tension, chronic 
angle-closure or 
pseudoexfoliative 
glaucoma. 
The relationship 
between a 
measure of the 
severity of visual 
field loss and 
subjective visual 
disability. 
The most frequently reported problems were 
grouped into the following four categories: 
outdoor mobility, glare and lighting conditions and 
activities demanding functional peripheral vision, 
household tasks, and personal care. These four 
factors accounted for 72% of the variability in the 
patients’ questionnaire responses. With 
increasing severity of binocular visual field loss 
there was an increase in the number of self-
reported visual problems. 
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severity of visual 
field loss. 
Nelson et 
al., 2003 
Quality of 
Life in 
Glaucoma 
and Its 
Relationshi
p with 
Visual 
Function 
Case-
control 
Quality of 
life 
(a) To explore 
patients' self-
reported visual 
disability resulting 
from glaucoma by 
means of a 
questionnaire; (b) 
To identify 
activities strongly 
associated with a 
measure of visual 
field loss, (c) to 
quantify different 
psychophysical 
aspects of visual 
function; (d) to 
assess the 
relationship 
between objective 
measures of 
visual function 
47 glaucoma 
patients and 19 
controls. Mean (SD) 
age = 67.72 (7.45) 
for the 18 patients 
with mild VF loss; 
67.21 (7.61) for the 
19 patients with 
moderate VF loss; 
71.70 (6.97) for the 
10 patients with 
severe VF loss; and 
66.50 (4.35) for the 
controls. 
Questionnaire 
responses (vision-
related quality of 
life, general health 
and psychosocial 
variables), visual 
acuity, visual fields, 
Esterman binocular 
disability scores, 
contrast sensitivity, 
critical flicker 
frequency, colour 
vision, dark 
adaptation, glare 
disability 
(brightness acuity), 
and stereoacuity 
scores were 
measured. 
Fifteen of the 50 questions were noted to have a 
strong significant relationship with a measure of 
visual field loss and were included in a new 
questionnaire scale, the Glaucoma Quality of Life 
– 15 (GQL-15). A significant relationship was 
found between the questionnaire summary 
performance measure and psychophysical tests: 
Pelli-Robson contrast sensitivity (r = −0.45, P < 
0.001), glare disability (r = −0.41, P < 0.001), 
Esterman binocular visual field test (r = −0.39, P < 
0.001), dark adaptation (r = 0.34, P = 0.007), and 
stereopsis (r = 0.26, P = 0.04). 
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and patients’ 
perception of their 
vision-related 
QoL. 
Onakoya 
et al., 
2012 
Quality of 
Life of 
Primary 
Open Angle 
Glaucoma 
Patients in 
Lagos, 
Nigeria: 
Clinical and 
Sociodemo
graphic 
Correlates 
Case-
control 
Quality of 
life 
To evaluate the 
QoL of POAG 
patients attending 
a tertiary eye 
institution in 
Lagos, Nigeria 
and identify 
clinical and 
sociodemographi
c factors affecting 
it. 
132 glaucoma cases 
and 132 controls. 
Mean (SD) age was 
58.58 (10.5 for 
glaucoma 
participants, and 
58.61 (10.56) for 
controls. 
QoL, as measured 
by the NEI-VFQ-25 
and the GQL-15. 
Also clinical and 
sociodemographic 
variables (e.g. 
colour vision, age 
etc).  
Early or mild glaucoma was associated with 
reduced QoL compared with the controls. 
Glaucoma patients had the greatest difficulty with 
glare and dark adaptation subscale of the GQL-
15. Increasing severity of disease defined by 
increasing visual field deficit (mean deviation 
values) correlated significantly with worsening 
QoL [Spearman r (r) values ranging from 0.32 to 
0.43]. Contrast sensitivity correlated moderately 
with QoL (r ranges from 0.43 to 0.47; P=0.001). 
Age had a negative impact on QoL (r= 0.30 for 
the NEIVFQ25 and 0.30 for the GQL-15) and 
affected all the subscales of the GQL-15 and 
most subscales of the NEI-VFQ-25. 
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Roux-
Sibilon et 
al., 2018 
Scene and 
human face 
recognition 
in the 
central 
vision of 
patients 
with 
glaucoma 
Case-
control 
Functional 
vision 
To assess visual 
abilities of scene 
and human face 
recognition in the 
central vision of 
POAG patients. 
22 participants with 
POAG. POAG 
participants were 
subdivided into 
those with a central 
vision defect (mean 
(SD) age = 67.9 
(10)) and those with 
no central defect 
(mean (SD) age = 
67.1 (9)). 25 controls 
(mean (SD) age = 
68.0 (6)). 
Performance on 
two different tasks 
where low-contrast 
stimuli were 
presented in the 
central 6⁰ of the 
visual field. A 
categorization task 
of 
scene images and 
human face 
images assessed 
high-level visual 
recognition 
abilities. In 
contrast, a 
detection task 
using the same 
stimuli assessed 
low-level visual 
function. 
Compared to controls, patients with a central 
visual defect showed a deficit in both detection 
and categorization of all low-contrast images. 
However, the deficit was greater for 
categorization than detection. Patients without a 
central defect showed similar performances to the 
controls concerning the detection and 
categorization of faces. However, while the 
detection of scene images was well-maintained, 
these patients showed a deficit in scene 
categorization. 
Sencanic 
et al., 
2018 
Validation 
of the 
Glaucoma 
Quality of 
Life-15 
Questionnai
re in 
Serbian 
language 
Cross-
sectional 
Quality of 
life 
To translate the 
GQL-15 into 
Serbian, and 
assess its validity 
and reliability in 
the population of 
Serbian patients. 
177 glaucoma 
patients (mean (SD) 
age = 62.83 
(13.60)). 101 had 
mild glaucoma, 38 
had moderate 
glaucoma and 38 
had severe 
glaucoma.  
All patients filled 
out the GQL-15 
and NEI-VFQ-25. 
The psychometric 
properties of the 
translated GQL-15 
were assessed by 
using classical test 
theory 
and Rasch 
analysis. 
The mean total score for the GQL-15 was 
20.68±7.31. The GQL-15 effectively discriminated 
advanced from mild and moderate glaucoma. Of 
the 4 domains, the glare and dark adaptation 
subscale showed the worse score, with no 
significant difference between mild and moderate 
glaucoma stages, but with advanced glaucoma 
participants showing significantly worse scores.  
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Sherwood 
et al., 
1998 
Glaucoma’s 
Impact on 
Quality of 
Life and Its 
Relation to 
Clinical 
Indicators 
Case-
control 
Quality of 
life 
To compare QoL 
of patients with 
glaucoma and 
control subjects, 
and to determine 
the relationships 
between QoL and 
demographic and 
clinical variables 
in patients with 
glaucoma. 
54 healthy 
participants (mean 
(SD) age = 62 
(11.1)); 56 
participants with 
glaucoma (mean 
(SD) age = 65.4 
(10.5)). An additional 
12 glaucoma 
participants were 
later included to 
examine 
relationships 
between glaucoma, 
therapy and QoL.   
The Medical 
Outcomes Study 
(MOS) scores, 
Activities of Daily 
Vision Scale 
(ADVS) scores, 
visual acuity, visual 
fields, and 
demographic 
variables were 
measured. 
Patients scored significantly lower than did the 
control subjects in all MOS-20 categories except 
pain. In patients, current medications and 
previous surgeries correlated with ADVS 
subscales night vision, near vision, and glare; 
visual acuity and fields correlated with MOS 
subscales physical, role and health, and all ADVS 
subscales.  
Siah et al., 
2018 
Macular 
pigment is 
associated 
with glare-
affected 
visual 
function and 
central 
visual field 
loss in 
glaucoma 
Cross-
sectional 
Psychoph
ysics 
To evaluate the 
relationship 
between macular 
pigment optical 
density (MPOD) 
and glare 
disability in open-
angle glaucoma. 
88 participants with 
POAG (median age 
= 67, range 36-84 
years).   
MPOD at 0.25°, 
0.5° and 1° of 
retinal eccentricity, 
measured using 
customised 
heterochromatic 
flicker photometry. 
Mesopic contrast 
sensitivity with 
glare (mCSg), 
photostress 
recovery time 
(PRT) and self-
reported glare 
symptoms were 
evaluated.  
Low spatial frequency mCSg was significantly 
correlated with MPOD at 0.25° (3 cycles per 
degree (cpd): r =0.25, P = 0.04) and 0.5° (3 cpd: 
r=0.23, P = 0.04) of retinal eccentricity. The depth 
of central 10° field loss was related to MPOD at 
all eccentricities (P <0.01 for all). Those who 
reported glare symptoms had a significantly lower 
MPOD at all retinal eccentricities (0.25° and 1°: P 
= 0.05 each; 0.5°: P = 0.04), including those with 
foveal involvement (0.25°: P = 0.05; 0.5°: P <0.01; 
1°: P = 0.01).  
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Skalicky et 
al., 2016 
Impact of 
age-related 
macular 
degeneratio
n in patients 
with 
glaucoma: 
understandi
ng the 
patients’ 
perspective 
Case-
control 
Quality of 
life 
To measure the 
impact of age-
related macular 
degeneration 
(AMD) on vision-
related activity 
limitation and 
preference-based 
status for 
glaucoma 
patients. 
200 glaucoma 
patients, of whom 73 
had AMD. 
Participants 
consisted of 
controls, who had 
glaucoma without 
AMD (mean (SD) 
age = 70.4 (9.6)); 
cases with glaucoma 
and low-risk AMD 
(mean (SD) age = 
76.4 (8.5); and 
cases with glaucoma 
and high-risk AMD 
(mean (SD) age = 
82.2 (7.1)).  
Vision-related 
activity limitation 
(as measured by 
the Glaucoma 
Activity Limitation-9 
questionnaire) and 
preference-based 
status (measured 
by the Visual 
Function 
Questionnaire 
Utility Index), for 
those with and 
without AMD. 
Lower better eye mean deviation (β: 1.42, 95% 
confidence interval: 1.24–1.63, P < 0.001) and 
AMD (β: 1.26 95% confidence interval: 1.10–1.44, 
P = 0.001) were independently associated with 
worse vision-related activity limitation. Glaucoma 
patients with AMD found using stairs, walking on 
uneven ground and judging distances of foot to 
step/curb significantly more difficult than those 
without AMD. 
Tam et al., 
2018 
Self-
perceived 
Impact of 
Glaucomato
us Visual 
Field Loss 
and Visual 
Disabilities 
on Driving 
Difficulty 
and 
Cessation 
Cross-
sectional 
ADL To investigate if 
glaucoma 
severity and the 
presence of self-
reported glare 
and difficulty with 
dark adaptation 
are associated 
with driving 
difficulty or 
cessation. 
99 participants with 
glaucoma. 53 
participants had mild 
glaucoma (mean 
(SD) age = 69.0 
(8.8)) and 46 had 
moderate glaucoma 
(mean (SD) age = 
74.4 (7.5)).   
Patient responses 
to the glare and 
dark adaptation 
subscales in 
Glaucoma Quality 
of Life-15 
questionnaire were 
used to measure 
relevant visual 
disability. 
Associations were 
assessed utilizing 
prevalence ratios 
(PR). 
19% of participants (19/99) reporting driving 
cessation. Patients with moderate/severe 
glaucoma when compared with mild glaucoma 
reported a significantly higher percentage of 
driving cessation (33% vs. 8%; P=0.002), 
presence of glare (27% vs. 6%; P=0.012), and 
difficulty with dark adaptation (31% vs. 10%; P= 
0.011). Individuals with self-perceived difficulty 
with dark adaptation were about 4 times more 
likely than those without to have difficulty driving 
at night (adjusted PR=3.94; P < 0.0001) or in poor 
driving conditions (adjusted PR=4.09; P=0.0002). 
Self-reported glare was associated with an 
increased risk of driving difficulty in poor driving 
conditions (PR=4.17; P= 0.05). 
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Tatemichi 
et al., 
2012 
Symptoms 
related to 
glaucomato
us visual 
field 
abnormalitie
s (VFAs) 
among 
male 
Japanese 
workers in a 
population-
based 
setting 
Cross-
sectional 
Functional 
vision 
To identify 
symptoms 
potentially related 
to VFAs in a 
population-based 
setting, and to 
assess the 
applicability of 
using these 
symptoms 
to identify 
persons at risk of 
developing 
glaucoma. 
10,214 Japanese 
male general 
workers (mean (SD) 
age = 45.3 (8.8)). 
9767 participants 
had no VFAs, 447 
participants had 
VFAs as determined 
by the frequency 
doubling technology 
(FDT), and 227 
participants had 
confirmed 
glaucomatous VFAs.   
Scores on a self-
administered 
questionnaire, 
which inquired 
about whether the 
participant was 
suffering from any 
of nine symptoms. 
Responses citing the symptoms ‘feeling of 
something in the front of the eye’ and ‘feeling of 
hardness to 
see in dark places’ were significantly (P < 0.05) 
more frequent in participants with FDT- and 
glaucomatous VFAs than among normal 
participants. However, the respective areas under 
the ROC curve of summed scores for the nine 
total items and for the two items which showed 
significant differences for the glaucoma groups 
were 0.57 (95% confidence interval = 0.53–0.60) 
and 0.58 (95% confidence interval = 0.54–0.61). 
Turano et 
al., 2002 
A Self-
Assessment 
Instrument 
Designed 
for 
Measuring 
Independen
t Mobility in 
RP 
Patients: 
Generalizab
ility to 
Glaucoma 
Patients 
Cross-
sectional 
ADL To determine 
whether the 
patient-based 
assessment 
of difficulty in 
mobility, 
developed and 
validated in a 
group of patients 
with retinitis 
pigmentosa (RP), 
is valid for 
measuring 
perceived visual 
ability for 
independent 
mobility in 
patients with 
glaucoma. 
83 glaucoma 
patients (mean (SD) 
age = 61.7 years 
(12.3).  
Participants’ 
ratings of the 
perceived difficulty 
of walking 
independently 
in each of 35 
mobility situations. 
A Rasch analysis 
of the ordinal 
difficulty ratings 
was used to 
estimate interval 
measures of 
perceived visual 
ability for 
independent 
mobility. 
Patients with glaucoma had, on average, higher 
perceived visual ability for independent mobility 
than those with RP. Glaucoma patients reported 
changes in lighting at night causing more mobility 
difficulties than the RP patients. 
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Velten et 
al., 2001 
The b-wave 
of the dark 
adapted 
flash 
electroretin
ogram in 
patients 
with 
advanced 
asymmetric
al glaucoma 
and normal 
subjects 
Case-
control 
Psychoph
ysics 
To evaluate 
whether the b-
wave of the dark 
adapted flash 
electroretinogram 
(ERG) is affected 
by glaucomatous 
damage. 
35 patients with 
advanced 
asymmetrical open 
angle glaucomas, 
primary and 
secondary 
(pseudoexfoliation 
syndrome and 
pigmentary 
dispersion) open 
angle and low 
tension glaucomas.  
17 healthy control 
subjects, matched 
for age and sex. 
Mean (SD) age = 56 
(10). 
The b-wave 
amplitudes and 
implicit times of all 
flash intensities 
tested and 
parameters Vmax, 
n, and K of the two 
models of the 
Naka-Rushton 
equation were 
compared between 
the normal subjects 
and those with 
glaucoma using the 
unpaired t test. 
Implicit times were significantly longer (p<0.005) 
in the glaucoma patients than in the normal group 
for flash intensities of 9.4, 5.3, 1.7, 0.53, and 0.17 
cd/s/m2. b-Wave amplitudes did not differ 
significantly between the two study groups.  
Willis et 
al., 2000 
Effects of 
Glaucoma 
and Aging 
on Photopic 
and 
Scotopic 
Motion 
Perception 
Case-
control 
Functional 
vision 
To examine the 
effects of primary 
open-angle 
glaucoma and 
normal aging on 
visual sensitivity 
for targets known 
to bias responses 
from the 
magnocellular 
visual processing 
stream. 
15 patients with 
POAG (mean (SD) 
age = 58.7 (11.9)); 
14 age-matched 
controls (mean (SD) 
age = 55.8 (10.5)); 
10 young controls 
(mean (SD) age = 
24.4 (2.1)). 
 
 
 
 
  
Contrast sensitivity 
was measured for 
the detection and 
direction 
discrimination of 
low-spatial-
frequency (0.5 
cyc/deg), drifting 
(4–24 Hz) 
sinusoidal gratings 
As a control, 
sensitivity was 
measured for the 
detection of 
stationary stimuli. 
Tests took place 
under both 
photopic and 
Across a wide range of conditions, the ability to 
detect and discriminate visual motion declined 
significantly (P < 0.05) with increasing age, 
whereas the ability to detect stationary patterns 
was generally unaffected. There were no 
significant differences in mean sensitivity between 
glaucoma and age-matched control groups for 
any of the conditions used. 
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scotopic levels of 
lighting. 
Wolffsohn 
et al., 
1998 
Low vision 
perspective
s on 
glaucoma 
Descripti
ve case 
series 
Functional 
vision 
The aim of this 
paper is to 
examine the 
demographics of 
patients with 
glaucoma-
induced visual 
impairment.  
The study involved a 
total of 590 patients 
with visual 
impairment. 
Glaucoma was the 
primary cause of 
visual loss in 8.5% 
of patients and was 
a secondary 
contributor to visual 
impairment in 5.9%. 
Data collected 
included age, 
subjective 
assessment of 
glare, mobility and 
visual needs, visual 
acuity (at distance 
and near), contrast 
sensitivity, visual 
field loss or 
disruption and 
magnifiers 
prescribed.  
Of patients whose primary cause of visual 
impairment was glaucoma, 34% reported being 
greatly affected by glare with a further 38% 
moderately affected. 64% of glaucoma patients 
had magnifiers prescribed to help them achieve 
their visual needs, which were to read 
newspapers in the majority of cases. 
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Wren et 
al., 2009 
Contrasting 
the Use of 
Two Vision-
Specific 
Quality of 
Life 
Questionnai
res in 
Subjects 
with Open-
Angle 
Glaucoma 
Cross-
sectional 
Quality of 
life 
To compare two 
vision-specific 
functional status 
measures to each 
other and to 
clinical 
parameters in the 
Collaborative 
Initial Glaucoma 
Treatment Study 
(CIGTS). 
426 participants with 
glaucoma. The 
average age of 
CIGTS participants 
who provided 
complete data at 54 
months was 57.8 
years.  
Scores on the 
Visual Activities 
Questionnaire 
(VAQ) and the NEI-
VFQ-25, as well as 
visual field and 
visual acuity 
measures. 
The VAQ subscales (range, 0 to 100) that 
assessed light-dark adaptation (mean=66.1), 
glare disability (66.4), and acuity/spatial vision 
(67.7) indicated vision-related functions that 
CIGTS participants found most difficult. On the 
NEI-VFQ, subjects reported high levels of visual 
functioning, with mean Z90 (out of 100) on the 
total score and in 9 of 12 subscales. Increasing 
VF loss was associated with a significant 
decrease in the overall and peripheral vision 
subscale scores from both questionnaires, and 
also several other subscales. 
Yonge et 
al., 2017 
Quantifying 
Fall-Related 
Hazards in 
the Homes 
of Persons 
with 
Glaucoma 
Cross-
sectional 
ADL To characterize 
fall-related 
hazards in the 
homes of persons 
with suspected or 
diagnosed 
glaucoma, and to 
determine 
whether those 
with worse visual 
field (VF) damage 
have fewer home 
hazards. 
174 participants with 
glaucoma. Mean 
(SD) age = 71.1 
(7.6).  
Total number of 
home hazards. 
The mean number of items graded per home was 
85.2 (SD = 13.2), and an average of 32.7 (38.3%) 
were identified as hazards. The bathroom 
contained the greatest number of hazards (mean 
= 7.9; 54.2% of graded items classified as 
hazardous), and the most common hazards 
identified in at least 1 room were ambient lighting 
<300 lux and exposed light bulbs. Only 27.9% of 
graded rooms had adequate lighting.  
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Zhou et 
al., 2014 
Quality of 
life of 
glaucoma 
patients in 
China: 
sociodemog
raphic, 
clinical, and 
psychologic
al 
correlates—
a cross-
sectional 
study 
Cross-
sectional 
Quality of 
life 
To assess vision-
related quality of 
life (VRQoL) in 
Chinese 
glaucoma 
patients and 
explore its 
sociodemographi
c, 
clinical and 
psychological 
correlates, and 
determine 
which of them 
explain the 
largest variation. 
508 glaucoma 
patients (mean (SD) 
age = 55.4 (15.2)). 
52.0% of 
participants had 
POAG and normal-
tension glaucoma, 
35.0% had primary 
angle closure 
glaucoma and 
13.0% had 
secondary 
glaucoma. 
Chinese-version 
Glaucoma Quality 
of Life-15 
questionnaire (CHI-
GQL-15) and 
Hospital Anxiety 
and Depression 
Scales were used 
to evaluate their 
VRQoL and 
psychological 
distresses 
respectively. 
Habitual-corrected 
visual acuity 
(HCVA), IOP, and 
mean defect (MD) 
of visual field) were 
assessed. 
The mean summary score for CHI-GQL-15 was 
28.79 ± 12.74. Patients exhibited the greatest 
difficulty in activities involving glare and dark 
adaptation (28.19 ± 22.86), followed by central 
and near vision (26.18 ± 26.56), peripheral vision 
(18.03 ± 21.37), and the least difficulty for outdoor 
mobility (15.06 ± 24.57).  
Zuege et 
al., 1967 
Studies of 
Dark 
Adaptation 
of Discrete 
Paracentral 
Retinal 
Areas in 
Glaucomato
us Subjects 
Cross-
sectional 
Psychoph
ysics 
To explore 
whether rod 
adaptation of the 
paracentral areas 
could be used in 
separating 
nonglaucomatous 
eyes from 
glaucoma eyes 
with field defects.  
67 patients with 
glaucoma, in the age 
range 20-81.  
The ratio of the 
dark-adaptation 
threshold at 30 
minutes, 15/30 
degrees from 
fixation. 
The ratio is well below unity and only very few 
non-glaucomatous eyes had a ratio which was 
above unity. The eyes with glaucoma fields, on 
the other hand, in the area of their visual field 
defect, were abnormal with the exception of the 
three eyes previously described. 
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Appendix 4: Relevant abstracts 
Table 7. Abstracts relevant to this review (ordered alphabetically by first author) 
Author(s) Year Abstract title Key findings  
Blumberg DM 
Liebmann JM 
Hiriji SH 
Hood DC 
2019 Diffuse Macular 
Damage in Mild 
to Moderate 
Glaucoma is 
Associated with 
Decreased 
Visual Function 
Scores under 
Low Luminance 
Conditions92 
“82 (65%) of the 126 better eyes (defined by 24-2 
VF MD) had evidence of macular damage, while 
the remaining 44 did not have macular damage. Of 
the 82 with damage, 33 (40%) had diffuse damage 
and 49 (60%) had focal damage. After adjusting for 
24-2 MD and age in the multivariable regression, 
diffuse macular damage remained a significant 
predictor of the Low Luminance Questionnaire 
(LLQ) subscales ‘difficulty with extreme lighting’ 
(p=0.0024), ‘‘difficulty with low lighting’ (p=0.037), 
and ‘diminished mobility’; (p=0.042). In contrast, 
there was no significant difference in LLQ scores in 
any subscale between participants with focal 
macular damage and those without macular 
damage.”  
Dintsios CM 
Scheibler FF 
Janssen I  
Gerber A  
Chernyak N  
Finger R 
2011 How Do 
Glaucoma 
Patients Assess 
Different 
Aspects of Their 
Treatment: An 
Elicitation of 
Patients' 
Preferences 
Using the 
Analytic 
Hierarchy 
Process93 
Patients rated the importance of different aspects 
of glaucoma treatment by a pairwise comparison. 
Of six domains, “Darkness and glare” was rated 
the third highest priority, after “Autonomy” and 
“Reading and seeing details”. The other three 
aspects, considered a lower patient priority, were 
“Peripheral vision”, “Side effects” and “Treatment-
related burden”.  
Hattori M 
Morikawa S 
Tsuneoka H 
1979 Night visual 
acuity of open 
angle 
glaucoma94 
The authors evaluated the night visual acuity in 6 
cases with ocular hypertension and in 10 cases 
with open angle glaucoma with defective visual 
field. All the cases with ocular hypertension 
showed normal night visual acuity. Cases with 
glaucoma, on the other hand, showed impaired 
night visual acuity. There was no correlation 
between the impaired night visual acuity and 
retarded dark adaptation in glaucoma subjects. 
Htoon HM 
Baskaran M 
Chay J 
Aw AT 
Aung T 
2014 Preliminary 
Estimation and 
Validation of the 
Glaucoma Utility 
Index-
Singapore95 
“70 primary glaucoma patients (72.9% with primary 
open angle) responses were collected: mean age 
68.2 years (±9.1), female (27.1%), glaucoma 
severity; (48.6% mild, 34.3% moderate, 17.1% 
severe). The significant estimated utility values 
comparing ‘no difficulty’ with ‘some/severe 
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Lamoureux EL 
Finkelstein EA 
difficulty’ in each of the dimensions were: central 
near vision (0.13, p=0.001), lighting and glare 
(0.20, p<0.001), mobility (0.32, p<0.001), 
psychosocial dimensions (0.19, p<0.001).” 
Lappas A 
Foerster AM 
Schild AM 
Rosentreter A 
Dietlein TS 
2011 Quantification of 
subjective visual 
quality of life in 
glaucoma 
patients : first 
results of a 
German version 
of the GQL-15 
questionnaire96 
A total of 31 patients were evaluated. It could be 
demonstrated that the QoL summary scores 
correlated with visual field loss. Evaluation of 
subscale scores of visual function revealed that 
glare and dark adaptation were correlated with 
glaucoma severity especially in the early stages of 
the disease. 
Mihailovic A  
Friedman DS  
West S 
Gitlin L 
Ramulu P 
2017 Gait changes 
across lighting 
conditions in 
persons with 
glaucoma97 
Glaucoma patients with worse integrated visual 
field sensitivity demonstrate more pronounced gait 
changes between normal and bright/dim lighting, 
suggesting greater challenges in mobility under the 
extremes of lighting. 
Mukherjee MR 
Mihailovic A 
Friedman DS 
West S 
Ramulu P 
2017 Initiation of 
walking in 
glaucoma98 
Glaucoma patients with worse vision take longer to 
initiate walking during bright-to-dim and obstructed 
pathway walking, and specific attention should be 
devoted to these scenarios when rehabilitating 
mobility in glaucoma. 
Ramsey DJ 
Alwreikat AM 
Cooper ML  
Roh S 
Bhardwaj MK,  
Kent-Gasiorowski A 
Bowen SA 
Cotran PR 
2019 Dark Adaptation 
Survey as a 
Predictive Tool 
for Primary 
Open-Angle 
Glaucoma99 
This pilot study revealed that problems with dark 
adaptation and vision under low luminance are 
commonly encountered by patients with POAG. 
These areas of visual disability are not assessed 
routinely in glaucoma care. A questionnaire 
assessing vision under low luminance and light–
dark transitions may serve as a proxy for functional 
impairment in glaucoma. When paired with risk 
factors such as structural features of the optic 
nerve and family history, this survey instrument 
may be suitable to screen for patients with POAG. 
Zenouda A 
Lombardi M 
Gutman E 
Brasnu E 
Hamard P 
Baudouin C 
Labbe A 
2016 Consequences 
of glaucoma on 
activities of daily 
living: 
Evaluation in an 
artificial street100 
Low light condition decreased mobility 
performance for all subjects (P <0.01). The 
influence of light condition was not different 
between the glaucoma and control group (P 
=0.16). The number of mobility incidents was not 
different between both groups (P =0.65). There 
was no difference in average movement onset 
(MO) time between the two groups (p=0,086) but 
glaucoma patients had a significantly longer overall 
movement (OM) time as compared to control 
subjects (OM delay: 151 ms, P <0.01). Low light 
condition increased the MO time by 4 to 20% 
(1.057 +/- 0.05 sec; 1.217 +/- 0.07 sec) for all 
subjects without difference between the two 
groups. 
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Zenouda A 
Lombardi M 
Gutman E  
Brasnu E  
Hamard P   
Sahel JA   
Baudouin C 
Labbe A 
2016 Effect of 
different 
lightning 
conditions on 
daily living 
activities of 
glaucoma 
patients71 
Glaucoma patients had decreased performance in 
mobility and motor control tasks. The influence of 
light condition was not different between the 
glaucoma and control group. 
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